{"protocolSection": {"identificationModule": {"nctId": "NCT02554786", "orgStudyIdInfo": {"id": "CQVM149B2301"}, "secondaryIdInfos": [{"id": "2015-002529-21", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Novartis", "class": "INDUSTRY"}, "briefTitle": "A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma", "officialTitle": "A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma"}, "statusModule": {"statusVerifiedDate": "2020-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2015-12-29", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2018-11-21", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-06-28", "type": "ACTUAL"}, "studyFirstSubmitDate": "2015-09-09", "studyFirstSubmitQcDate": "2015-09-17", "studyFirstPostDateStruct": {"date": "2015-09-18", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-12-19", "resultsFirstSubmitQcDate": "2020-02-21", "resultsFirstPostDateStruct": {"date": "2020-03-05", "type": "ACTUAL"}, "dispFirstSubmitDate": "2019-06-03", "dispFirstSubmitQcDate": "2019-10-17", "dispFirstPostDateStruct": {"date": "2019-11-05", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2020-02-21", "lastUpdatePostDateStruct": {"date": "2020-03-05", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Novartis Pharmaceuticals", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "The purpose of the trial is to evaluate the efficacy and safety of two different doses of QMF149 (QMF149 150/160 \u00b5g and QMF149 150/320 \u00b5g via Concept1) over two respective MF doses (MF 400 \u00b5g and MF 800 \u00b5g via Twisthaler\u00ae (total daily dose)) in poorly controlled asthmatic participants as determined by pulmonary function testing, and effects on asthma control"}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["QMF149, Mometasone furoate (MF), asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 2216, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "QMF149 150/160 \u00b5g", "type": "EXPERIMENTAL", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered once daily (o.d) via Concept1 inhaler in the evening.", "interventionNames": ["Drug: Indacaterol acetate/Mometasone furoate"]}, {"label": "QMF149 150/320 \u00b5g", "type": "EXPERIMENTAL", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d via Concept1 inhaler in the evening.", "interventionNames": ["Drug: Indacaterol acetate/Mometasone furoate"]}, {"label": "MF 400 \u00b5g", "type": "ACTIVE_COMPARATOR", "description": "Mometasone furoate (MF) 400 \u03bcg was delivered o.d via Twisthaler\u00ae in the evening", "interventionNames": ["Drug: Mometasone furoate"]}, {"label": "Salmeterol /fluticasone 50/500 \u03bcg", "type": "ACTIVE_COMPARATOR", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae.", "interventionNames": ["Drug: Salmeterol xinafoate/fluticasone propionate"]}, {"label": "MF 800 \u03bcg", "type": "ACTIVE_COMPARATOR", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae.", "interventionNames": ["Drug: Mometasone furoate"]}], "interventions": [{"type": "DRUG", "name": "Indacaterol acetate/Mometasone furoate", "armGroupLabels": ["QMF149 150/160 \u00b5g", "QMF149 150/320 \u00b5g"], "otherNames": ["QMF149"]}, {"type": "DRUG", "name": "Mometasone furoate", "armGroupLabels": ["MF 400 \u00b5g", "MF 800 \u03bcg"]}, {"type": "DRUG", "name": "Salmeterol xinafoate/fluticasone propionate", "armGroupLabels": ["Salmeterol /fluticasone 50/500 \u03bcg"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Trough Forced Expiratory Volume in One Second (Trough FEV1) at Week 26", "description": "Trough FEV1 was assessed by performing spirometric assessment. It is defined as average of the two FEV1 measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "timeFrame": "26 weeks"}], "secondaryOutcomes": [{"measure": "Asthma Control Questionnaire (ACQ-7) at Weeks 4, 12, 26 and 52", "description": "The ACQ-7 measured asthma symptom control and consists of 7 items: 5 on symptom assessment, 1 on rescue bronchodilator use and 1 on airway calibre (FEV1 % predicted). All 7 questions of the ACQ-7 were equally weighted. Items 1-5 were scored along a 7-point response scale, where 0 = totally controlled and 6 = severely uncontrolled. Item 6 is scored between 0 = no rescue medication and 6 = More than 16 puffs/inhalations most days. The 7th item was scored by the investigator based on the FEV1 % predicted from the masterscope at the site (i.e., Score = 0 means \\> 95% of predicted FEV1, 1 = 90 - 95%, 2 = 80 - 89%, 3 = 70 - 79%, 4 = 60 - 69%, 5 = 50 - 59%, and Score = 6 means \\< 50% of predicted FEV1). The total score was calculated as the mean of all questions.", "timeFrame": "Weeks 4, 12, 26 and 52"}, {"measure": "Trough FEV1 at Week 52", "description": "Trough FEV1 was assessed by performing spirometric assessment. It is defined as average of the two FEV1 measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "timeFrame": "Week 52"}, {"measure": "Pre-dose FEV1 at Weeks 4 and 12", "description": "Pre-dose trough FEV1 is defined as average of the two FEV1 measurements taken 45 min and 15 min pre evening dose. It was assessed by performing spirometric assessment. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "timeFrame": "Weeks 4 (Day 30) and 12 (Day 86)"}, {"measure": "Post Dose FEV1 (5 Minutes-1 Hour)", "description": "Post-dose FEV1 measurements were analyzed at 5 minutes, 15 minutes, 30 minutes and 1 hour. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "timeFrame": "Up to Week 52 (Day 364)"}, {"measure": "Trough Forced Vital Capacity (FVC)", "description": "FVC is the total amount of air exhaled during the FEV test. Trough FVC is defined as average of the two FVC measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. It was assessed by performing spirometric assessment.", "timeFrame": "Up to Week 52 (Day 365)"}, {"measure": "Trough Forced Expiratory Flow (FEF)Between 25% and 75% of FVC (FEF25-75)", "description": "FEF is the flow (or speed) of air coming out of the lung during the middle portion of a forced expiration. Trough FEF25-75% is defined as average of the two FEF25-75% measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. It was assessed by performing spirometric assessment.", "timeFrame": "Up to Week 52 (Day 365)"}, {"measure": "Change From Baseline in Morning and Evening Peak Expiratory Flow Rate (PEF) Over 26 and 52 Weeks of Treatment", "description": "PEF is a person's maximum speed of expiration. All the participants were instructed to record PEF twice daily using a mini Peak Flow Meter device, once in the morning (before taking the morning dose) and once approximately 12 h later in the evening (before taking the evening dose). At each timepoint, the participant was instructed to perform 3 consecutive manoeuvres within 10 minutes. These PEF values were captured in the e-PEF/diary. The best of 3 values were used.", "timeFrame": "Up to Weeks 26 and 52"}, {"measure": "Percentage of Participants Achieving the Minimal Important Difference (MID) ACQ \u2265 0.5 at Weeks 26 and 52", "description": "Change from baseline in ACQ-7 scores of \u2264 0.5 was defined as minimal clinically important difference and were considered clinically meaningful. The ACQ-7 measured asthma symptom control and consists of 7 items: 5 on symptom assessment, 1 on rescue bronchodilator use and 1 on airway calibre (FEV1 % predicted). All 7 questions of the ACQ-7 were equally weighted. Items 1-5 were scored along a 7-point response scale, where 0 = totally controlled and 6 = severely uncontrolled. Item 6 is scored between 0 = no rescue medication and 6 = More than 16 puffs/inhalations most days. The 7th item was scored by the investigator based on the FEV1 % predicted from the masterscope at the site (i.e., Score = 0 means \\> 95% of predicted FEV1, 1 = 90 - 95%, 2 = 80 - 89%, 3 = 70 - 79%, 4 = 60 - 69%, 5 = 50 - 59%, and Score = 6 means \\< 50% of predicted FEV1). The total score was calculated as the mean of all questions", "timeFrame": "Weeks 26 (Day 183) and 52 (Day 364)"}, {"measure": "Change From Baseline in Percentage of Asthma Symptoms Free Days", "description": "All participants were provided with an electronic diary (e-Diary) to record clinical symptoms. They were instructed to routinely complete the e-Diary twice daily at the same time each morning and again approximately 12 hours later in the evening. The e-Diary was reviewed at each visit until study completion. Asthma symptoms free days are days with no daytime symptoms, no night-time awakenings and no symptoms on awakening. The daytime asthma symptom score was based on the daily e-diary recordings by participants with respect to shortness of breath, wheeze, cough, chest tightness, and impact on usual daily activities due to symptoms.", "timeFrame": "Up to Week 52"}, {"measure": "Change Form Baseline in Percentage of Days With no Daytime Symptoms", "description": "All participants were provided with an electronic diary (e-Diary) to record clinical symptoms. They were instructed to routinely complete the e-Diary twice daily at the same time each morning and again approximately 12 hours later in the evening. The e-Diary was reviewed at each visit until study completion. For days with no daytime symptoms, all 5 evening questions must have a score = 0 with respect to shortness of breath, wheeze, cough, chest tightness and impact on usual daily activities due to symptoms, each with scores from 0 (no problems) to 4 (very severe problems).", "timeFrame": "Up to Week 52"}, {"measure": "Change From Baseline in Percentage of Nights With no Night-time Awakenings", "description": "All participants were provided with an electronic diary (e-Diary) to record clinical symptoms. They were instructed to routinely complete the e-Diary twice daily at the same time each morning and again approximately 12 hours later in the evening. The e-Diary was reviewed at each visit until study completion. The question asked for nights with no night-time awakenings was \"How did you sleep last night?\" had to be answered with \"I did not wake up because of any breathing problems\" with scores from 0 (no problem)-4 (very severe problems).", "timeFrame": "Up to Week 52"}, {"measure": "Change Form Baseline in Percentage of Mornings With no Symptoms on Awakening", "description": "All participants were provided with an electronic diary (e-Diary) to record clinical symptoms. They were instructed to routinely complete the e-Diary twice daily at the same time each morning and again approximately 12 hours later in the evening. The e-Diary was reviewed at each visit until study completion. The question asked for mornings with no symptoms on awakening was \"Did you have asthma symptoms upon awakening in the morning?\" to be answered with \"None\" with scores from 0 (no problem)-4 (very severe problems).", "timeFrame": "Up to Week 52"}, {"measure": "Rescue Medication Usage", "description": "All participants were given salbutamol/albuterol to use as rescue medication throughout the study along with e-Diary to record rescue medication use. The number of puffs of rescue medication during the past 12 hours is recorded twice (morning/evening) by the participant prior to taking study medication. The mean daily number of puffs of rescue medication use will be calculated for each participant, done separately for morning (night-time), evening (daytime), and daily (night-time plus daytime) rescue medication use", "timeFrame": "Up to Weeks 26 and 52"}, {"measure": "Time to First Asthma Exacerbation by Exacerbation Category", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "timeFrame": "Up to Week 52"}, {"measure": "Time to First Hospitalization for Asthma Exacerbation", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "timeFrame": "Up to Week 52"}, {"measure": "Annual Rate of Asthma Exacerbations by Exacerbation Category", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "timeFrame": "Up to Week 52"}, {"measure": "Duration in Days of Asthma Exacerbations by Exacerbation Category", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "timeFrame": "Up to Week 52"}, {"measure": "Percentage of Participants With at Least One Asthma Exacerbation by Exacerbation Category", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "timeFrame": "Up to Week 52"}, {"measure": "Time in Days to Permanent Discontinuation of Study Medication Due to Asthma Exacerbations", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "timeFrame": "Up to Week 52"}, {"measure": "Percentage of Participants Who Permanently Discontinued Study Medication Due to Asthma Exacerbations", "timeFrame": "Up to Week 52"}, {"measure": "Total Amounts of Systemic Corticosteroids (in Doses) Used to Treat Asthma Exacerbations", "description": "The treatment of asthma exacerbations including the initiation of systemic corticosteroids were done according to investigator's or treating physician's medical judgement and in line with national and international recommendations. If systemic corticosteroids were required, a participant could return to the study after successfully completing a taper of approximately 7-10 days.", "timeFrame": "Up to Week 52"}, {"measure": "Change From Baseline in Percentage of Rescue Medication Free Days", "description": "All participants were given salbutamol/albuterol to use as rescue medication throughout the study along with e-Diary to record rescue medication use. Rescue medication free days is defined as any day where the participant did not use any puffs of rescue medication during daytime and night-time.", "timeFrame": "Up to Weeks 26 and 52"}, {"measure": "Asthma Quality of Life Questionnaire (AQLQ)", "description": "AQLQ is a 32-item disease specific questionnaire designed to measure functional impairments that are most important to patients with asthma, with a recall time of two weeks and each question to be answered on a 7-point scale (1-totally limited/problems all the time, 7-not at all limited/no problems). It consists of 4 domains:\n\n* Symptoms = Mean of Items 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 29, 30 (12 items)\n* Activity limitation = Mean of Items 1, 2, 3, 4, 5, 11, 19, 25, 28, 31, 32 (11 items)\n* Emotional function = Mean of Items 7, 13, 15, 21, 27 (5 items)\n* Environmental stimuli = Mean of Items 9, 17, 23, 26 (4 items)\n* Overall Score = Mean of Items 1 to 32 (32 items)", "timeFrame": "Up to Week 52 (Day 364)"}, {"measure": "Trough FEV1 Measured After 26 Weeks of Treatment", "description": "Trough FEV1 was assessed by performing spirometric assessment. It is defined as average of the two FEV1 measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "timeFrame": "Week 26"}, {"measure": "Percentage of Participants With Composite Endpoint of Serious Asthma Outcomes", "description": "A composite endpoint of serious asthma outcomes is defined as asthma-related hospitalization, asthma-related intubation, or asthma-related death and was reviewed by the Adjudication Committee.", "timeFrame": "Up to Week 52"}, {"measure": "Percentage of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)", "description": "An AE is any untoward medical occurrence (i.e., any unfavorable and unintended sign including abnormal laboratory findings, symptom or disease) in a participant or clinical investigation participant after providing written informed consent for participation in the study. An SAE is defined as any adverse event (appearance of (or worsening of any pre-existing) undesirable sign(s), symptom(s) or medical conditions(s) which meets any one of the following criteria: is fatal or life-threatening, results in persistent or significant disability/incapacity, constitutes a congenital anomaly/birth defect, requires inpatient hospitalization or prolongation of existing hospitalization or is medically significant, i.e. defined as an event that jeopardizes the participants or may require medical or surgical intervention.", "timeFrame": "Approximately up to 56 weeks"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Participants with a diagnosis of asthma, for a period of at least 1 year prior to Visit 1 (Screening)\n* Participants who have used medium or high dose inhaled corticosteroids (ICS) or low dose of long acting beta-2 agonist (LABA)/ICS combinations for asthma for at least 3 months and at stable doses for at least 1 month prior to Visit 1\n* Participants must have ACQ-7 score \u2265 1.5 at Visit 101 and at Visit 102 (prior to double-blind treatment) and qualify for treatment with medium or high dose LABA/ICS\n* Pre-bronchodilator \u2265 50% Forced expiratory volume in 1 second (FEV1) of \\< 85 % of the predicted normal value for the participants after withholding bronchodilators at both Visit 101 and 102, according to American Thoracic Society/European Respiratory Society (ATS/ERS) criteria.\n* Withholding period of bronchodilators prior to spirometry: short acting beta-2 agonist (SABA) for \u2265 6 hours and FDC or free combinations of ICS/LABA for \u2265 48 hours, short acting anticholinergics (SAMA) for \u2265 8 hours, xanthines \\>=07 days\n* A one-time repeat/re-testing of percent predicted FEV1 (prebronchodilator FEV1) is allowed at Visit 101 and at Visit 102.\n\nSpacer devices are permitted for reversibility testing only.\n\n-Participants who demonstrate an increase in FEV1 of 12% and 200 mL within 30 minutes after administration of 400 \u00b5g salbutamol/360 \u00b5g albuterol (or equivalent dose) at Visit 101 All participants must perform a reversibility test at Visit 101\n\nIf reversibility is not demonstrated at Visit 101:\n\n* Reversibility should be repeated once-\n* Participants may be permitted to enter the study with historical evidence of reversibility that was performed according to ATS/ERS guidelines within 2 years prior to Visit 1\n* Alternatively, participants may be permitted to enter the study with a historical positive bronchoprovocation test that was performed within 2 years prior to Visit 1.\n\nExclusion Criteria:\n\n* Participants who have smoked or inhaled tobacco products within the 6 month period prior to Visit 1, or who have a smoking history of greater than 10 pack years. This includes use of nicotine inhalers such as e-cigarettes at the time of Visit 1\n* Participants who have had an asthma attack/exacerbation requiring systemic steroids or hospitalization or emergency room visit within 6 weeks of Visit 1 (Screening)\n* Participants who have ever required intubation for a severe asthma attack/exacerbation.\n* Participants who have a clinical condition which is likely to be worsened by ICS administration (e.g. glaucoma, cataract and fragility fractures) who are according to investigator's medical judgment at risk participating in the study).\n* Participants who have had a respiratory tract infection or asthma worsening as determined by the investigator within 4 weeks prior to Visit 1 (Screening) or between Visit 1 and Visit 102. Participants may be re-screened 4 weeks after recovery from their respiratory tract infection or asthma worsening.\n* Participants with a history of chronic lung diseases other than asthma, including (but not limited to) Chronic Obstructive Pulmonary Disease (COPD), sarcoidosis, interstitial lung disease, cystic fibrosis, clinically significant bronchiectasis and active tuberculosis.\n* Participants with severe narcolepsy and/or insomnia.\n* Participants who have a clinically significant electrocardiogram (ECG) abnormality at Visit 101 (Start of Run- In epoch) and at any time between Visit 101 and Visit 102 (including unscheduled ECG). ECG evidence of myocardial infarction at Visit 101 (via central reader) should be clinically assessed by the investigator with supportivedocumentation\n* Participants with a history of hypersensitivity to lactose, any of the study drugs or to similar drugs within the class including untoward reactions to sympathomimetic amines or inhaled medication or any component thereof\n* Participants who have not achieved an acceptable spirometry results at Visit 101 in accordance with ATS/ERS criteria for acceptability and repeatability (rescreening allowed only once).\n\nRepeat spirometry may be allowed once in an ad-hoc visit if the spirometry did not qualify due to ATS/ERS criteria. If the participant fails the repeat assessment, the participant may be rescreened once\n\n* Participants on Maintenance Immunotherapy (desensitization) for allergies or less than 3 months prior to Visit 101 or participants on Maintenance Immunotherapy for more than 3 months prior to Visit 101 but expected to change throughout the course of the study.\n* Women of child-bearing potential, defined as all women physiologically capable of becoming pregnant, unless they are using highly effective methods of contraception during dosing of study treatment and for 30 days after stopping of study treatment.\n* Long acting muscarinic antagonist (LAMA) use within 3 months prior to Visit 101", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "12 Years", "maximumAge": "75 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Novartis Investigative Site", "city": "Birmingham", "state": "Alabama", "zip": "35244", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Novartis Investigative Site", "city": "Los Angeles", "state": "California", "zip": "90025", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "Novartis Investigative Site", "city": "Orange", "state": "California", "zip": "92868", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -117.85311}}, {"facility": "Novartis Investigative Site", "city": "Riverside", "state": "California", "zip": "92506", "country": "United States", "geoPoint": {"lat": 33.95335, "lon": -117.39616}}, {"facility": "Novartis Investigative Site", "city": "San Diego", "state": "California", "zip": "92117", "country": "United States", "geoPoint": {"lat": 32.71533, "lon": -117.15726}}, {"facility": "Novartis Investigative Site", "city": "San Jose", "state": "California", "zip": "95117", "country": "United States", "geoPoint": {"lat": 37.33939, "lon": -121.89496}}, {"facility": "Novartis Investigative Site", "city": "Stockton", "state": "California", "zip": "95207", "country": "United States", "geoPoint": {"lat": 37.9577, "lon": -121.29078}}, {"facility": "Novartis Investigative Site", "city": "Westminster", "state": "California", "zip": "92683", "country": "United States", "geoPoint": {"lat": 33.75918, "lon": -118.00673}}, {"facility": "Novartis Investigative Site", "city": "Denver", "state": "Colorado", "zip": "80230", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "Novartis Investigative Site", "city": "Miami", "state": "Florida", "zip": "33144", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "Novartis Investigative Site", "city": "Tallahassee", "state": "Florida", "zip": "32308", "country": "United States", "geoPoint": {"lat": 30.43826, "lon": -84.28073}}, {"facility": "Novartis Investigative Site", "city": "Winter Park", "state": "Florida", "zip": "32789", "country": "United States", "geoPoint": {"lat": 28.6, "lon": -81.33924}}, {"facility": "Novartis Investigative Site", "city": "Baltimore", "state": "Maryland", "zip": "21236", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "Novartis Investigative Site", "city": "Waldorf", "state": "Maryland", "zip": "20602", "country": "United States", "geoPoint": {"lat": 38.62456, "lon": -76.93914}}, {"facility": "Novartis Investigative Site", "city": "North Dartmouth", "state": "Massachusetts", "zip": "02747-3322", "country": "United States", "geoPoint": {"lat": 41.63899, "lon": -70.97032}}, {"facility": "Novartis Investigative Site", "city": "Saint Louis", "state": "Missouri", "zip": "63141", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "Novartis Investigative Site", "city": "Bellevue", "state": "Nebraska", "zip": "68123", "country": "United States", "geoPoint": {"lat": 41.13667, "lon": -95.89084}}, {"facility": "Novartis Investigative Site", "city": "Las Vegas", "state": "Nevada", "zip": "89119", "country": "United States", "geoPoint": {"lat": 36.17497, "lon": -115.13722}}, {"facility": "Novartis Investigative Site", "city": "Skillman", "state": "New Jersey", "zip": "08558", "country": "United States", "geoPoint": {"lat": 40.42011, "lon": -74.7146}}, {"facility": "Novartis Investigative Site", "city": "Cortland", "state": "New York", "zip": "13045", "country": "United States", "geoPoint": {"lat": 42.60118, "lon": -76.18048}}, {"facility": "Novartis Investigative Site", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73120", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "Novartis Investigative Site", "city": "Tulsa", "state": "Oklahoma", "zip": "74136", "country": "United States", "geoPoint": {"lat": 36.15398, "lon": -95.99277}}, {"facility": "Novartis Investigative Site", "city": "Medford", "state": "Oregon", "zip": "97504", "country": "United States", "geoPoint": {"lat": 42.32652, "lon": -122.87559}}, {"facility": "Novartis Investigative Site", "city": "Portland", "state": "Oregon", "zip": "97213", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Novartis Investigative Site", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15241", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Novartis Investigative Site", "city": "North Charleston", "state": "South Carolina", "zip": "29407", "country": "United States", "geoPoint": {"lat": 32.85462, "lon": -79.97481}}, {"facility": "Novartis Investigative Site", "city": "Boerne", "state": "Texas", "zip": "78006", "country": "United States", "geoPoint": {"lat": 29.79466, "lon": -98.73197}}, {"facility": "Novartis Investigative Site", "city": "El Paso", "state": "Texas", "zip": "79903", "country": "United States", "geoPoint": {"lat": 31.75872, "lon": -106.48693}}, {"facility": "Novartis Investigative Site", "city": "Greenfield", "state": "Wisconsin", "zip": "53228", "country": "United States", "geoPoint": {"lat": 42.9614, "lon": -88.01259}}, {"facility": "Novartis Investigative Site", "city": "Plovdiv", "state": "BGR", "zip": "4000", "country": "Bulgaria", "geoPoint": {"lat": 42.15, "lon": 24.75}}, {"facility": "Novartis Investigative Site", "city": "Varna", "state": "BGR", "zip": "9000", "country": "Bulgaria", "geoPoint": {"lat": 43.21667, "lon": 27.91667}}, {"facility": "Novartis Investigative Site", "city": "Vidin", "state": "BGR", "zip": "3703", "country": "Bulgaria", "geoPoint": {"lat": 43.99, "lon": 22.8725}}, {"facility": "Novartis Investigative Site", "city": "Pleven", "zip": "5800", "country": "Bulgaria", "geoPoint": {"lat": 43.41667, "lon": 24.61667}}, {"facility": "Novartis Investigative Site", "city": "Plovdiv", "zip": "4002", "country": "Bulgaria", "geoPoint": {"lat": 42.15, "lon": 24.75}}, {"facility": "Novartis Investigative Site", "city": "Ruse", "zip": "7002", "country": "Bulgaria", "geoPoint": {"lat": 43.85639, "lon": 25.97083}}, {"facility": "Novartis Investigative Site", "city": "Sofia", "zip": "1407", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"facility": "Novartis Investigative Site", "city": "Sofia", "zip": "1431", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"facility": "Novartis Investigative Site", "city": "Sofia", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"facility": "Novartis Investigative Site", "city": "Stara Zagora", "zip": "6000", "country": "Bulgaria", "geoPoint": {"lat": 42.43278, "lon": 25.64194}}, {"facility": "Novartis Investigative Site", "city": "Troyan", "zip": "5600", "country": "Bulgaria", "geoPoint": {"lat": 42.89427, "lon": 24.71589}}, {"facility": "Novartis Investigative Site", "city": "Beijing", "state": "Beijing", "zip": "100044", "country": "China", "geoPoint": {"lat": 39.9075, "lon": 116.39723}}, {"facility": "Novartis Investigative Site", "city": "Beijing", "state": "Beijing", "zip": "100730", "country": "China", "geoPoint": {"lat": 39.9075, "lon": 116.39723}}, {"facility": "Novartis Investigative Site", "city": "Fuzhou", "state": "Fujian", "zip": "350025", "country": "China", "geoPoint": {"lat": 26.06139, "lon": 119.30611}}, {"facility": "Novartis Investigative Site", "city": "Guang Zhou", "state": "Guangdong", "zip": "510120", "country": "China"}, {"facility": "Novartis Investigative Site", "city": "Haikou", "state": "Hainan", "zip": "570311", "country": "China", "geoPoint": {"lat": 20.04583, "lon": 110.34167}}, {"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "state": "Hebei", "zip": "050000", "country": "China", "geoPoint": {"lat": 38.04139, "lon": 114.47861}}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "state": "Hubei", "zip": "430030", "country": "China", "geoPoint": {"lat": 30.58333, "lon": 114.26667}}, {"facility": "Novartis Investigative Site", "city": "Changsha", "state": "Hunan", "zip": "410011", "country": "China", "geoPoint": {"lat": 28.19874, "lon": 112.97087}}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "state": "Jiangsu", "zip": "210006", "country": "China", "geoPoint": {"lat": 32.06167, "lon": 118.77778}}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "state": "Jiangsu", "zip": "210009", "country": "China", "geoPoint": {"lat": 32.06167, "lon": 118.77778}}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "state": "Jiangsu", "zip": "210029", "country": "China", "geoPoint": {"lat": 32.06167, "lon": 118.77778}}, {"facility": "Novartis Investigative Site", "city": "Suzhou", "state": "Jiangsu", "zip": "215006", "country": "China", "geoPoint": {"lat": 31.30408, "lon": 120.59538}}, {"facility": "Novartis Investigative Site", "city": "Chang Chun", "state": "Jilin", "zip": "130021", "country": "China", "geoPoint": {"lat": 42.74694, "lon": 126.24667}}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "state": "Liaoning", "zip": "110000", "country": "China", "geoPoint": {"lat": 41.79222, "lon": 123.43278}}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "state": "Liaoning", "zip": "110003", "country": "China", "geoPoint": {"lat": 41.79222, "lon": 123.43278}}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "state": "Liaoning", "zip": "110011", "country": "China", "geoPoint": {"lat": 41.79222, "lon": 123.43278}}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "state": "Shanghai", "zip": "200032", "country": "China", "geoPoint": {"lat": 31.22222, "lon": 121.45806}}, {"facility": "Novartis Investigative Site", "city": "Xian", "state": "Shanxi", "zip": "710061", "country": "China", "geoPoint": {"lat": 34.25833, "lon": 108.92861}}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "state": "Sichuan", "zip": "610041", "country": "China", "geoPoint": {"lat": 30.66667, "lon": 104.06667}}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "state": "Zhejiang", "zip": "310006", "country": "China", "geoPoint": {"lat": 30.29365, "lon": 120.16142}}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "state": "Zhejiang", "zip": "310014", "country": "China", "geoPoint": {"lat": 30.29365, "lon": 120.16142}}, {"facility": "Novartis Investigative Site", "city": "Beijing", "zip": "100029", "country": "China", "geoPoint": {"lat": 39.9075, "lon": 116.39723}}, {"facility": "Novartis Investigative Site", "city": "Beijing", "zip": "100191", "country": "China", "geoPoint": {"lat": 39.9075, "lon": 116.39723}}, {"facility": "Novartis Investigative Site", "city": "Beijing", "zip": "100730", "country": "China", "geoPoint": {"lat": 39.9075, "lon": 116.39723}}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "zip": "610083", "country": "China", "geoPoint": {"lat": 30.66667, "lon": 104.06667}}, {"facility": "Novartis Investigative Site", "city": "Chongqing", "zip": "400038", "country": "China", "geoPoint": {"lat": 29.56278, "lon": 106.55278}}, {"facility": "Novartis Investigative Site", "city": "Guang Zhou", "zip": "510080", "country": "China"}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "zip": "510000", "country": "China", "geoPoint": {"lat": 23.11667, "lon": 113.25}}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "zip": "510180", "country": "China", "geoPoint": {"lat": 23.11667, "lon": 113.25}}, {"facility": "Novartis Investigative Site", "city": "Nanchang", "zip": "330006", "country": "China", "geoPoint": {"lat": 28.68396, "lon": 115.85306}}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "zip": "200092", "country": "China", "geoPoint": {"lat": 31.22222, "lon": 121.45806}}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "zip": "200433", "country": "China", "geoPoint": {"lat": 31.22222, "lon": 121.45806}}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "zip": "300052", "country": "China", "geoPoint": {"lat": 39.14222, "lon": 117.17667}}, {"facility": "Novartis Investigative Site", "city": "Varazdin", "state": "HRV", "zip": "42000", "country": "Croatia", "geoPoint": {"lat": 46.30444, "lon": 16.33778}}, {"facility": "Novartis Investigative Site", "city": "Zagreb", "state": "HRV", "zip": "10 000", "country": "Croatia", "geoPoint": {"lat": 45.81444, "lon": 15.97798}}, {"facility": "Novartis Investigative Site", "city": "Petrinja", "zip": "44250", "country": "Croatia", "geoPoint": {"lat": 45.4375, "lon": 16.29}}, {"facility": "Novartis Investigative Site", "city": "Rijeka", "zip": "51000", "country": "Croatia", "geoPoint": {"lat": 45.32674, "lon": 14.44239}}, {"facility": "Novartis Investigative Site", "city": "Zadar", "zip": "23000", "country": "Croatia", "geoPoint": {"lat": 44.11972, "lon": 15.24222}}, {"facility": "Novartis Investigative Site", "city": "Zagreb", "zip": "10000", "country": "Croatia", "geoPoint": {"lat": 45.81444, "lon": 15.97798}}, {"facility": "Novartis Investigative Site", "city": "Beroun", "state": "Czech Republic", "zip": "266 01", "country": "Czechia", "geoPoint": {"lat": 49.96382, "lon": 14.072}}, {"facility": "Novartis Investigative Site", "city": "Boskovice", "state": "Czech Republic", "zip": "680 01", "country": "Czechia", "geoPoint": {"lat": 49.48751, "lon": 16.65997}}, {"facility": "Novartis Investigative Site", "city": "Jablonec nad Nisou", "state": "Czech Republic", "zip": "466 01", "country": "Czechia", "geoPoint": {"lat": 50.72431, "lon": 15.17108}}, {"facility": "Novartis Investigative Site", "city": "Jindrichuv Hradec", "state": "Czech Republic", "zip": "377 01", "country": "Czechia", "geoPoint": {"lat": 49.14404, "lon": 15.00301}}, {"facility": "Novartis Investigative Site", "city": "Kurim", "state": "Czech Republic", "zip": "66434", "country": "Czechia", "geoPoint": {"lat": 49.29852, "lon": 16.53144}}, {"facility": "Novartis Investigative Site", "city": "Praha", "state": "Czech Republic", "zip": "14800", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Novartis Investigative Site", "city": "Teplice", "state": "Czech Republic", "zip": "415 01", "country": "Czechia", "geoPoint": {"lat": 50.6404, "lon": 13.82451}}, {"facility": "Novartis Investigative Site", "city": "Varnsdorf", "state": "Czech Republic", "zip": "40747", "country": "Czechia", "geoPoint": {"lat": 50.91154, "lon": 14.61824}}, {"facility": "Novartis Investigative Site", "city": "Ostrava", "state": "CZE", "zip": "709 00", "country": "Czechia", "geoPoint": {"lat": 49.83465, "lon": 18.28204}}, {"facility": "Novartis Investigative Site", "city": "Plzen", "state": "CZE", "zip": "301 00", "country": "Czechia", "geoPoint": {"lat": 49.74747, "lon": 13.37759}}, {"facility": "Novartis Investigative Site", "city": "Teplice", "state": "CZE", "zip": "415 01", "country": "Czechia", "geoPoint": {"lat": 50.6404, "lon": 13.82451}}, {"facility": "Novartis Investigative Site", "city": "Breclav", "zip": "690 02", "country": "Czechia", "geoPoint": {"lat": 48.75897, "lon": 16.88203}}, {"facility": "Novartis Investigative Site", "city": "Cesky Krumlov", "zip": "381 01", "country": "Czechia", "geoPoint": {"lat": 48.81091, "lon": 14.31521}}, {"facility": "Novartis Investigative Site", "city": "Kutna Hora", "zip": "28401", "country": "Czechia", "geoPoint": {"lat": 49.94839, "lon": 15.26816}}, {"facility": "Novartis Investigative Site", "city": "Novy Bor", "zip": "47301", "country": "Czechia", "geoPoint": {"lat": 50.75761, "lon": 14.55555}}, {"facility": "Novartis Investigative Site", "city": "Plzen", "zip": "323 00", "country": "Czechia", "geoPoint": {"lat": 49.74747, "lon": 13.37759}}, {"facility": "Novartis Investigative Site", "city": "Praha 8", "zip": "182 00", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Novartis Investigative Site", "city": "Rokycany", "zip": "337 22", "country": "Czechia", "geoPoint": {"lat": 49.7427, "lon": 13.59459}}, {"facility": "Novartis Investigative Site", "city": "Tabor", "zip": "390 01", "country": "Czechia", "geoPoint": {"lat": 49.41441, "lon": 14.6578}}, {"facility": "Novartis Investigative Site", "city": "Alexandria", "zip": "21131", "country": "Egypt", "geoPoint": {"lat": 31.21564, "lon": 29.95527}}, {"facility": "Novartis Investigative Site", "city": "Tallinn", "zip": "13619", "country": "Estonia", "geoPoint": {"lat": 59.43696, "lon": 24.75353}}, {"facility": "Novartis Investigative Site", "city": "Tartu", "zip": "51014", "country": "Estonia", "geoPoint": {"lat": 58.38062, "lon": 26.72509}}, {"facility": "Novartis Investigative Site", "city": "Peine", "state": "Niedersachsen", "zip": "31224", "country": "Germany", "geoPoint": {"lat": 52.31928, "lon": 10.2352}}, {"facility": "Novartis Investigative Site", "city": "Koblenz", "state": "Rheinland-Pfalz", "zip": "56068", "country": "Germany", "geoPoint": {"lat": 50.35357, "lon": 7.57883}}, {"facility": "Novartis Investigative Site", "city": "Ahlen", "zip": "59229", "country": "Germany", "geoPoint": {"lat": 51.76338, "lon": 7.8887}}, {"facility": "Novartis Investigative Site", "city": "Bamberg", "zip": "96049", "country": "Germany", "geoPoint": {"lat": 49.89873, "lon": 10.90067}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10119", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10247", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10367", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10717", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10787", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10969", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12157", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12159", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12203", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12627", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "13057", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "13086", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "13156", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "13187", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Bochum", "zip": "D-44787", "country": "Germany", "geoPoint": {"lat": 51.48165, "lon": 7.21648}}, {"facility": "Novartis Investigative Site", "city": "Boehlen", "zip": "04564", "country": "Germany"}, {"facility": "Novartis Investigative Site", "city": "Bonn", "zip": "53119", "country": "Germany", "geoPoint": {"lat": 50.73438, "lon": 7.09549}}, {"facility": "Novartis Investigative Site", "city": "Delitzsch", "zip": "04509", "country": "Germany", "geoPoint": {"lat": 51.52546, "lon": 12.34284}}, {"facility": "Novartis Investigative Site", "city": "Dresden", "zip": "01069", "country": "Germany", "geoPoint": {"lat": 51.05089, "lon": 13.73832}}, {"facility": "Novartis Investigative Site", "city": "Dueren", "zip": "52349", "country": "Germany"}, {"facility": "Novartis Investigative Site", "city": "D\u00fcsseldorf", "zip": "40211", "country": "Germany", "geoPoint": {"lat": 51.22172, "lon": 6.77616}}, {"facility": "Novartis Investigative Site", "city": "Erlangen", "zip": "91052", "country": "Germany", "geoPoint": {"lat": 49.59099, "lon": 11.00783}}, {"facility": "Novartis Investigative Site", "city": "Frankfurt", "zip": "60313", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "Novartis Investigative Site", "city": "Frankfurt", "zip": "60389", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "Novartis Investigative Site", "city": "Furstenwalde", "zip": "15517", "country": "Germany", "geoPoint": {"lat": 52.36067, "lon": 14.06185}}, {"facility": "Novartis Investigative Site", "city": "Halle", "zip": "06108", "country": "Germany", "geoPoint": {"lat": 51.48159, "lon": 11.97948}}, {"facility": "Novartis Investigative Site", "city": "Hamburg", "zip": "20354", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Novartis Investigative Site", "city": "Hamburg", "zip": "22143", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Novartis Investigative Site", "city": "Hamburg", "zip": "22299", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Novartis Investigative Site", "city": "Hamburg", "zip": "22335", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Novartis Investigative Site", "city": "Hannover", "zip": "30173", "country": "Germany", "geoPoint": {"lat": 52.37052, "lon": 9.73322}}, {"facility": "Novartis Investigative Site", "city": "Hochstadt", "zip": "91315", "country": "Germany", "geoPoint": {"lat": 49.70617, "lon": 10.81329}}, {"facility": "Novartis Investigative Site", "city": "Kassel", "zip": "34121", "country": "Germany", "geoPoint": {"lat": 51.31667, "lon": 9.5}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04103", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04109", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04207", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04275", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Lubeck", "zip": "23552", "country": "Germany", "geoPoint": {"lat": 53.86893, "lon": 10.68729}}, {"facility": "Novartis Investigative Site", "city": "Ludwigsburg", "zip": "71640", "country": "Germany", "geoPoint": {"lat": 48.89731, "lon": 9.19161}}, {"facility": "Novartis Investigative Site", "city": "Marburg", "zip": "D-35037", "country": "Germany", "geoPoint": {"lat": 50.80904, "lon": 8.77069}}, {"facility": "Novartis Investigative Site", "city": "Mittweida", "zip": "09648", "country": "Germany", "geoPoint": {"lat": 50.98622, "lon": 12.97537}}, {"facility": "Novartis Investigative Site", "city": "Muenchen", "zip": "81377", "country": "Germany", "geoPoint": {"lat": 51.60698, "lon": 13.31243}}, {"facility": "Novartis Investigative Site", "city": "Neu Isenburg", "zip": "63263", "country": "Germany", "geoPoint": {"lat": 50.04832, "lon": 8.69406}}, {"facility": "Novartis Investigative Site", "city": "Neuss", "zip": "41462", "country": "Germany", "geoPoint": {"lat": 51.19807, "lon": 6.68504}}, {"facility": "Novartis Investigative Site", "city": "Potsdam", "zip": "14467", "country": "Germany", "geoPoint": {"lat": 52.39886, "lon": 13.06566}}, {"facility": "Novartis Investigative Site", "city": "Potsdam", "zip": "14469", "country": "Germany", "geoPoint": {"lat": 52.39886, "lon": 13.06566}}, {"facility": "Novartis Investigative Site", "city": "Rheine", "zip": "48431", "country": "Germany", "geoPoint": {"lat": 52.28509, "lon": 7.44055}}, {"facility": "Novartis Investigative Site", "city": "Rudersdorf", "zip": "15562", "country": "Germany", "geoPoint": {"lat": 51.1, "lon": 11.45}}, {"facility": "Novartis Investigative Site", "city": "Schleswig", "zip": "24837", "country": "Germany", "geoPoint": {"lat": 54.52156, "lon": 9.5586}}, {"facility": "Novartis Investigative Site", "city": "Schwedt", "zip": "16303", "country": "Germany"}, {"facility": "Novartis Investigative Site", "city": "Weinheim", "zip": "69469", "country": "Germany", "geoPoint": {"lat": 49.54887, "lon": 8.66697}}, {"facility": "Novartis Investigative Site", "city": "Witten", "zip": "58452", "country": "Germany", "geoPoint": {"lat": 51.44362, "lon": 7.35258}}, {"facility": "Novartis Investigative Site", "city": "Ciudad", "state": "Gautemala", "zip": "01010", "country": "Guatemala"}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "state": "GTM", "zip": "01010", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "state": "GTM", "zip": "01011", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "zip": "01010", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "zip": "01011", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "zip": "01057", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "state": "HUN", "zip": "1037", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "state": "HUN", "zip": "1089", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "state": "HUN", "zip": "1117", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "state": "HUN", "zip": "1204", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Gyor", "state": "HUN", "zip": "9024", "country": "Hungary", "geoPoint": {"lat": 47.68333, "lon": 17.63512}}, {"facility": "Novartis Investigative Site", "city": "Hajdunanas", "state": "HUN", "zip": "4080", "country": "Hungary", "geoPoint": {"lat": 47.85, "lon": 21.43333}}, {"facility": "Novartis Investigative Site", "city": "Mako", "state": "HUN", "zip": "6900", "country": "Hungary", "geoPoint": {"lat": 46.21667, "lon": 20.48333}}, {"facility": "Novartis Investigative Site", "city": "Miskolc", "state": "HUN", "zip": "3529", "country": "Hungary", "geoPoint": {"lat": 48.1, "lon": 20.78333}}, {"facility": "Novartis Investigative Site", "city": "Puspokladany", "state": "HUN", "zip": "4150", "country": "Hungary", "geoPoint": {"lat": 47.31667, "lon": 21.11667}}, {"facility": "Novartis Investigative Site", "city": "Szazhalombatta", "state": "HUN", "zip": "2440", "country": "Hungary", "geoPoint": {"lat": 47.32579, "lon": 18.92141}}, {"facility": "Novartis Investigative Site", "city": "Balassagyarmat", "zip": "2660", "country": "Hungary", "geoPoint": {"lat": 48.07296, "lon": 19.29614}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1106", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1134", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Cegled", "zip": "2700", "country": "Hungary", "geoPoint": {"lat": 47.17266, "lon": 19.79952}}, {"facility": "Novartis Investigative Site", "city": "Csorna", "zip": "H-9300", "country": "Hungary", "geoPoint": {"lat": 47.61155, "lon": 17.25012}}, {"facility": "Novartis Investigative Site", "city": "Dombovar", "zip": "7200", "country": "Hungary", "geoPoint": {"lat": 46.37657, "lon": 18.13696}}, {"facility": "Novartis Investigative Site", "city": "Godollo", "zip": "2100", "country": "Hungary", "geoPoint": {"lat": 47.59657, "lon": 19.35515}}, {"facility": "Novartis Investigative Site", "city": "Hatvan", "zip": "3000", "country": "Hungary", "geoPoint": {"lat": 47.66667, "lon": 19.68333}}, {"facility": "Novartis Investigative Site", "city": "Komarom", "zip": "2900", "country": "Hungary", "geoPoint": {"lat": 47.74318, "lon": 18.11913}}, {"facility": "Novartis Investigative Site", "city": "Miskolc", "zip": "3526", "country": "Hungary", "geoPoint": {"lat": 48.1, "lon": 20.78333}}, {"facility": "Novartis Investigative Site", "city": "Mosdos", "zip": "7257", "country": "Hungary", "geoPoint": {"lat": 46.35379, "lon": 17.98853}}, {"facility": "Novartis Investigative Site", "city": "Szarvas", "zip": "5540", "country": "Hungary", "geoPoint": {"lat": 46.86667, "lon": 20.55}}, {"facility": "Novartis Investigative Site", "city": "Szeged", "zip": "6720", "country": "Hungary", "geoPoint": {"lat": 46.253, "lon": 20.14824}}, {"facility": "Novartis Investigative Site", "city": "Szeged", "zip": "6722", "country": "Hungary", "geoPoint": {"lat": 46.253, "lon": 20.14824}}, {"facility": "Novartis Investigative Site", "city": "Szigetvar", "zip": "7900", "country": "Hungary", "geoPoint": {"lat": 46.04865, "lon": 17.80554}}, {"facility": "Novartis Investigative Site", "city": "Szombathely", "zip": "9700", "country": "Hungary", "geoPoint": {"lat": 47.23088, "lon": 16.62155}}, {"facility": "Novartis Investigative Site", "city": "New Delhi", "state": "Delhi", "zip": "110007", "country": "India", "geoPoint": {"lat": 28.63576, "lon": 77.22445}}, {"facility": "Novartis Investigative Site", "city": "Ahmedabad", "state": "Gujarat", "zip": "380 008", "country": "India", "geoPoint": {"lat": 23.02579, "lon": 72.58727}}, {"facility": "Novartis Investigative Site", "city": "Ahmedabad", "state": "Gujarat", "zip": "380016", "country": "India", "geoPoint": {"lat": 23.02579, "lon": 72.58727}}, {"facility": "Novartis Investigative Site", "city": "Vadodara", "state": "Gujarat", "zip": "390021", "country": "India", "geoPoint": {"lat": 22.29941, "lon": 73.20812}}, {"facility": "Novartis Investigative Site", "city": "Mysore", "state": "Karnataka", "zip": "570001", "country": "India", "geoPoint": {"lat": 12.29791, "lon": 76.63925}}, {"facility": "Novartis Investigative Site", "city": "Kozhikode", "state": "Kerala", "zip": "673008", "country": "India", "geoPoint": {"lat": 11.24802, "lon": 75.7804}}, {"facility": "Novartis Investigative Site", "city": "Mumbai", "state": "Maharashtra", "zip": "400601", "country": "India", "geoPoint": {"lat": 19.07283, "lon": 72.88261}}, {"facility": "Novartis Investigative Site", "city": "Nagpur", "state": "Maharashtra", "zip": "440010", "country": "India", "geoPoint": {"lat": 21.14631, "lon": 79.08491}}, {"facility": "Novartis Investigative Site", "city": "Nagpur", "state": "Maharashtra", "zip": "440012", "country": "India", "geoPoint": {"lat": 21.14631, "lon": 79.08491}}, {"facility": "Novartis Investigative Site", "city": "Nagpur", "state": "Maharashtra", "zip": "440019", "country": "India", "geoPoint": {"lat": 21.14631, "lon": 79.08491}}, {"facility": "Novartis Investigative Site", "city": "Pune", "state": "Maharashtra", "zip": "411007", "country": "India", "geoPoint": {"lat": 18.51957, "lon": 73.85535}}, {"facility": "Novartis Investigative Site", "city": "Mohali", "state": "Punjab", "zip": "160 062", "country": "India", "geoPoint": {"lat": 30.67995, "lon": 76.72211}}, {"facility": "Novartis Investigative Site", "city": "Jaipur", "state": "Rajasthan", "zip": "302001", "country": "India", "geoPoint": {"lat": 26.91962, "lon": 75.78781}}, {"facility": "Novartis Investigative Site", "city": "Jaipur", "state": "Rajasthan", "zip": "302013", "country": "India", "geoPoint": {"lat": 26.91962, "lon": 75.78781}}, {"facility": "Novartis Investigative Site", "city": "Jaipur", "state": "Rajasthan", "zip": "302020", "country": "India", "geoPoint": {"lat": 26.91962, "lon": 75.78781}}, {"facility": "Novartis Investigative Site", "city": "Jaipur", "state": "Rajasthan", "zip": "302023", "country": "India", "geoPoint": {"lat": 26.91962, "lon": 75.78781}}, {"facility": "Novartis Investigative Site", "city": "Hyderabad", "state": "Telangana", "zip": "500082", "country": "India", "geoPoint": {"lat": 17.38405, "lon": 78.45636}}, {"facility": "Novartis Investigative Site", "city": "Lucknow", "state": "Uttar Pradesh", "zip": "226003", "country": "India", "geoPoint": {"lat": 26.83928, "lon": 80.92313}}, {"facility": "Novartis Investigative Site", "city": "New Delhi", "zip": "110029", "country": "India", "geoPoint": {"lat": 28.63576, "lon": 77.22445}}, {"facility": "Novartis Investigative Site", "city": "Wilton", "state": "Cork", "country": "Ireland"}, {"facility": "Novartis Investigative Site", "city": "County Limerick", "zip": "V94 F858", "country": "Ireland"}, {"facility": "Novartis Investigative Site", "city": "Dublin", "zip": "DUBLIN 8", "country": "Ireland", "geoPoint": {"lat": 53.33306, "lon": -6.24889}}, {"facility": "Novartis Investigative Site", "city": "Ichihara-city", "state": "Chiba", "zip": "299-0111", "country": "Japan", "geoPoint": {"lat": 35.51667, "lon": 140.08333}}, {"facility": "Novartis Investigative Site", "city": "Fukuoka-city", "state": "Fukuoka", "zip": "819-8555", "country": "Japan", "geoPoint": {"lat": 33.6, "lon": 130.41667}}, {"facility": "Novartis Investigative Site", "city": "Kasuga-city", "state": "Fukuoka", "zip": "816-0813", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Yanagawa-city", "state": "Fukuoka", "zip": "832-0059", "country": "Japan", "geoPoint": {"lat": 33.16667, "lon": 130.4}}, {"facility": "Novartis Investigative Site", "city": "Obihiro-city", "state": "Hokkaido", "zip": "080-0013", "country": "Japan", "geoPoint": {"lat": 42.91722, "lon": 143.20444}}, {"facility": "Novartis Investigative Site", "city": "Himeji-city", "state": "Hyogo", "zip": "671-0102", "country": "Japan", "geoPoint": {"lat": 34.81667, "lon": 134.7}}, {"facility": "Novartis Investigative Site", "city": "Himeji-city", "state": "Hyogo", "zip": "672-8064", "country": "Japan", "geoPoint": {"lat": 34.81667, "lon": 134.7}}, {"facility": "Novartis Investigative Site", "city": "Naka-gun", "state": "Ibaraki", "zip": "319-1113", "country": "Japan", "geoPoint": {"lat": 36.05, "lon": 140.16667}}, {"facility": "Novartis Investigative Site", "city": "Atsugi-city", "state": "Kanagawa", "zip": "243-0034", "country": "Japan", "geoPoint": {"lat": 35.44272, "lon": 139.36931}}, {"facility": "Novartis Investigative Site", "city": "Kawasaki-city", "state": "Kanagawa", "zip": "255", "country": "Japan", "geoPoint": {"lat": 35.52056, "lon": 139.71722}}, {"facility": "Novartis Investigative Site", "city": "Yokohama-city", "state": "Kanagawa", "zip": "223-0059", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Novartis Investigative Site", "city": "Yokohama-city", "state": "Kanagawa", "zip": "231-8682", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Novartis Investigative Site", "city": "Yokohama-city", "state": "Kanagawa", "zip": "236-0004", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Novartis Investigative Site", "city": "Yokohama", "state": "Kanagawa", "zip": "232-0064", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Novartis Investigative Site", "city": "Sendai-city", "state": "Miyagi", "zip": "980-0871", "country": "Japan", "geoPoint": {"lat": 38.26667, "lon": 140.86667}}, {"facility": "Novartis Investigative Site", "city": "Okayama-city", "state": "Okayama", "zip": "702-8055", "country": "Japan", "geoPoint": {"lat": 34.65, "lon": 133.93333}}, {"facility": "Novartis Investigative Site", "city": "Kishiwada-city", "state": "Osaka", "zip": "596-8501", "country": "Japan", "geoPoint": {"lat": 34.46667, "lon": 135.36667}}, {"facility": "Novartis Investigative Site", "city": "Osaka city", "state": "Osaka", "zip": "530 0001", "country": "Japan", "geoPoint": {"lat": 34.69374, "lon": 135.50218}}, {"facility": "Novartis Investigative Site", "city": "Takatsuki-city", "state": "Osaka", "zip": "569-1192", "country": "Japan", "geoPoint": {"lat": 34.84833, "lon": 135.61678}}, {"facility": "Novartis Investigative Site", "city": "Toyonaka-city", "state": "Osaka", "country": "Japan", "geoPoint": {"lat": 34.78244, "lon": 135.46932}}, {"facility": "Novartis Investigative Site", "city": "Yao-city", "state": "Osaka", "zip": "581-0011", "country": "Japan", "geoPoint": {"lat": 34.61667, "lon": 135.6}}, {"facility": "Novartis Investigative Site", "city": "Koshigaya-city", "state": "Saitama", "zip": "343-8555", "country": "Japan", "geoPoint": {"lat": 35.89035, "lon": 139.78916}}, {"facility": "Novartis Investigative Site", "city": "Tokyo", "state": "Shibuya Ku", "zip": "150 0013", "country": "Japan", "geoPoint": {"lat": 35.6895, "lon": 139.69171}}, {"facility": "Novartis Investigative Site", "city": "Chuo ku", "state": "Tokyo", "zip": "103 0027", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "Novartis Investigative Site", "city": "Chuou-ku", "state": "Tokyo", "zip": "103-0028", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Itabashi-ku", "state": "Tokyo", "zip": "173-8610", "country": "Japan", "geoPoint": {"lat": 35.74893, "lon": 139.71497}}, {"facility": "Novartis Investigative Site", "city": "Setagaya-Ku", "state": "Tokyo", "zip": "157-0072", "country": "Japan", "geoPoint": {"lat": 35.64825, "lon": 139.65376}}, {"facility": "Novartis Investigative Site", "city": "Shinjuku-ku", "state": "Tokyo", "zip": "162-0053", "country": "Japan", "geoPoint": {"lat": 35.2946, "lon": 139.57059}}, {"facility": "Novartis Investigative Site", "city": "Shinjuku-ku", "state": "Tokyo", "zip": "169-0073", "country": "Japan", "geoPoint": {"lat": 35.2946, "lon": 139.57059}}, {"facility": "Novartis Investigative Site", "city": "Toshima ku", "state": "Tokyo", "zip": "170 0003", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Toshima-ku", "state": "Tokyo", "zip": "171-0014", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Cheongju si", "state": "Chungcheongbuk Do", "zip": "28644", "country": "Korea, Republic of", "geoPoint": {"lat": 36.63722, "lon": 127.48972}}, {"facility": "Novartis Investigative Site", "city": "Wonju", "state": "Gangwon-do", "zip": "26427", "country": "Korea, Republic of", "geoPoint": {"lat": 37.35139, "lon": 127.94528}}, {"facility": "Novartis Investigative Site", "city": "Bundang Gu", "state": "Gyeonggi Do", "zip": "13620", "country": "Korea, Republic of"}, {"facility": "Novartis Investigative Site", "city": "Bucheon-Si", "state": "Gyeonggi-Do", "zip": "14584", "country": "Korea, Republic of", "geoPoint": {"lat": 37.49889, "lon": 126.78306}}, {"facility": "Novartis Investigative Site", "city": "Seoul", "state": "Korea", "zip": "03312", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "Novartis Investigative Site", "city": "Seoul", "state": "Korea", "zip": "08308", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "Novartis Investigative Site", "city": "Seoul", "state": "Seocho Gu", "zip": "06591", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "Novartis Investigative Site", "city": "Incheon", "zip": "403-720", "country": "Korea, Republic of", "geoPoint": {"lat": 37.45646, "lon": 126.70515}}, {"facility": "Novartis Investigative Site", "city": "Riga", "state": "LV", "zip": "1011", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Daugavpils", "zip": "LV-5401", "country": "Latvia", "geoPoint": {"lat": 55.88333, "lon": 26.53333}}, {"facility": "Novartis Investigative Site", "city": "Riga", "zip": "LV 1002", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Riga", "zip": "LV-1001", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "state": "LTU", "zip": "LT-48259", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "zip": "LT-49449", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Siauliai", "zip": "LT-76231", "country": "Lithuania", "geoPoint": {"lat": 55.93333, "lon": 23.31667}}, {"facility": "Novartis Investigative Site", "city": "Utena", "zip": "LT-28151", "country": "Lithuania", "geoPoint": {"lat": 55.49765, "lon": 25.59918}}, {"facility": "Novartis Investigative Site", "city": "Vilnius", "zip": "LT-09108", "country": "Lithuania", "geoPoint": {"lat": 54.68916, "lon": 25.2798}}, {"facility": "Novartis Investigative Site", "city": "Mexicali", "state": "Baja California", "zip": "21100", "country": "Mexico", "geoPoint": {"lat": 32.62781, "lon": -115.45446}}, {"facility": "Novartis Investigative Site", "city": "Ciudad de Mexico", "state": "Distrito Federal", "zip": "06700", "country": "Mexico", "geoPoint": {"lat": 19.42847, "lon": -99.12766}}, {"facility": "Novartis Investigative Site", "city": "Mexico", "state": "Distrito Federal", "zip": "14050", "country": "Mexico", "geoPoint": {"lat": 19.42847, "lon": -99.12766}}, {"facility": "Novartis Investigative Site", "city": "Mexico", "zip": "07760", "country": "Mexico", "geoPoint": {"lat": 19.42847, "lon": -99.12766}}, {"facility": "Novartis Investigative Site", "city": "Lodz", "state": "POL", "zip": "91-110", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "Novartis Investigative Site", "city": "Wejherowo", "state": "POL", "zip": "84-200", "country": "Poland", "geoPoint": {"lat": 54.60568, "lon": 18.23559}}, {"facility": "Novartis Investigative Site", "city": "Aleksandrow Odzki", "zip": "95-070", "country": "Poland"}, {"facility": "Novartis Investigative Site", "city": "Biaystok", "zip": "15-430", "country": "Poland"}, {"facility": "Novartis Investigative Site", "city": "Bielsko-Biala", "zip": "43-300", "country": "Poland", "geoPoint": {"lat": 49.82245, "lon": 19.04686}}, {"facility": "Novartis Investigative Site", "city": "Elblag", "zip": "82-300", "country": "Poland", "geoPoint": {"lat": 54.1522, "lon": 19.40884}}, {"facility": "Novartis Investigative Site", "city": "Inowroclaw", "zip": "88-100", "country": "Poland", "geoPoint": {"lat": 52.79886, "lon": 18.26387}}, {"facility": "Novartis Investigative Site", "city": "Katowice", "zip": "40 085", "country": "Poland", "geoPoint": {"lat": 50.25841, "lon": 19.02754}}, {"facility": "Novartis Investigative Site", "city": "Krakow", "zip": "30033", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Novartis Investigative Site", "city": "Lodz", "zip": "90-302", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "Novartis Investigative Site", "city": "Ostrow Wielkopolski", "zip": "63-400", "country": "Poland", "geoPoint": {"lat": 51.65501, "lon": 17.80686}}, {"facility": "Novartis Investigative Site", "city": "Sopot", "zip": "81-741", "country": "Poland", "geoPoint": {"lat": 54.4418, "lon": 18.56003}}, {"facility": "Novartis Investigative Site", "city": "Warsaw", "zip": "01518", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "Novartis Investigative Site", "city": "Zawadzkie", "zip": "47-120", "country": "Poland", "geoPoint": {"lat": 50.60503, "lon": 18.48467}}, {"facility": "Novartis Investigative Site", "city": "Iasi", "state": "Jud Iasi", "zip": "700732", "country": "Romania", "geoPoint": {"lat": 47.16667, "lon": 27.6}}, {"facility": "Novartis Investigative Site", "city": "Constanta", "state": "Jud. Constanta", "zip": "900002", "country": "Romania", "geoPoint": {"lat": 44.18073, "lon": 28.63432}}, {"facility": "Novartis Investigative Site", "city": "Craiova", "state": "Jud.Dolj", "zip": "200341", "country": "Romania", "geoPoint": {"lat": 44.31667, "lon": 23.8}}, {"facility": "Novartis Investigative Site", "city": "Bucharest", "state": "ROM", "zip": "12071", "country": "Romania", "geoPoint": {"lat": 44.43225, "lon": 26.10626}}, {"facility": "Novartis Investigative Site", "city": "Craiova", "state": "ROM", "zip": "000000", "country": "Romania", "geoPoint": {"lat": 44.31667, "lon": 23.8}}, {"facility": "Novartis Investigative Site", "city": "Craiova", "state": "ROM", "zip": "200712", "country": "Romania", "geoPoint": {"lat": 44.31667, "lon": 23.8}}, {"facility": "Novartis Investigative Site", "city": "Deva", "state": "ROM", "zip": "330084", "country": "Romania", "geoPoint": {"lat": 45.88333, "lon": 22.9}}, {"facility": "Novartis Investigative Site", "city": "Timisoara", "state": "ROM", "zip": "300298", "country": "Romania", "geoPoint": {"lat": 45.75372, "lon": 21.22571}}, {"facility": "Novartis Investigative Site", "city": "Timisoara", "state": "Timis", "zip": "300310", "country": "Romania", "geoPoint": {"lat": 45.75372, "lon": 21.22571}}, {"facility": "Novartis Investigative Site", "city": "Arad", "zip": "310013", "country": "Romania", "geoPoint": {"lat": 46.18333, "lon": 21.31667}}, {"facility": "Novartis Investigative Site", "city": "Bacau", "zip": "600114", "country": "Romania", "geoPoint": {"lat": 46.56718, "lon": 26.91384}}, {"facility": "Novartis Investigative Site", "city": "Bragadiru", "zip": "077025", "country": "Romania", "geoPoint": {"lat": 44.37111, "lon": 25.9775}}, {"facility": "Novartis Investigative Site", "city": "Braila", "zip": "810003", "country": "Romania", "geoPoint": {"lat": 45.26667, "lon": 27.98333}}, {"facility": "Novartis Investigative Site", "city": "Brasov", "zip": "500051", "country": "Romania", "geoPoint": {"lat": 45.64861, "lon": 25.60613}}, {"facility": "Novartis Investigative Site", "city": "Bucharest", "zip": "020125", "country": "Romania", "geoPoint": {"lat": 44.43225, "lon": 26.10626}}, {"facility": "Novartis Investigative Site", "city": "Bucuresti", "zip": "012363", "country": "Romania", "geoPoint": {"lat": 44.42802, "lon": 26.09665}}, {"facility": "Novartis Investigative Site", "city": "Bucuresti", "zip": "050554", "country": "Romania", "geoPoint": {"lat": 44.42802, "lon": 26.09665}}, {"facility": "Novartis Investigative Site", "city": "Cluj Napoca", "zip": "400275", "country": "Romania", "geoPoint": {"lat": 46.76667, "lon": 23.6}}, {"facility": "Novartis Investigative Site", "city": "Cluj Napoca", "zip": "400371", "country": "Romania", "geoPoint": {"lat": 46.76667, "lon": 23.6}}, {"facility": "Novartis Investigative Site", "city": "Cluj-Napoca", "zip": "400371", "country": "Romania", "geoPoint": {"lat": 46.76667, "lon": 23.6}}, {"facility": "Novartis Investigative Site", "city": "Codlea", "zip": "505100", "country": "Romania", "geoPoint": {"lat": 45.7, "lon": 25.45}}, {"facility": "Novartis Investigative Site", "city": "Craiova", "zip": "200515", "country": "Romania", "geoPoint": {"lat": 44.31667, "lon": 23.8}}, {"facility": "Novartis Investigative Site", "city": "Ramnicu Valcea", "zip": "240564", "country": "Romania", "geoPoint": {"lat": 45.1, "lon": 24.36667}}, {"facility": "Novartis Investigative Site", "city": "Suceava", "zip": "720284", "country": "Romania", "geoPoint": {"lat": 47.63333, "lon": 26.25}}, {"facility": "Novartis Investigative Site", "city": "Targu Mures", "zip": "540072", "country": "Romania", "geoPoint": {"lat": 46.54245, "lon": 24.55747}}, {"facility": "Novartis Investigative Site", "city": "Chelyabinsk", "zip": "454021", "country": "Russian Federation", "geoPoint": {"lat": 55.15402, "lon": 61.42915}}, {"facility": "Novartis Investigative Site", "city": "Chelyabinsk", "zip": "454076", "country": "Russian Federation", "geoPoint": {"lat": 55.15402, "lon": 61.42915}}, {"facility": "Novartis Investigative Site", "city": "Kazan", "zip": "420012", "country": "Russian Federation", "geoPoint": {"lat": 55.78874, "lon": 49.12214}}, {"facility": "Novartis Investigative Site", "city": "Krasnoyarsk", "zip": "660022", "country": "Russian Federation", "geoPoint": {"lat": 56.01839, "lon": 92.86717}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "105275", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "119192", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "N.Novgorod", "zip": "603126", "country": "Russian Federation"}, {"facility": "Novartis Investigative Site", "city": "Novosibirsk", "zip": "630047", "country": "Russian Federation", "geoPoint": {"lat": 55.0415, "lon": 82.9346}}, {"facility": "Novartis Investigative Site", "city": "Novosibirsk", "zip": "630099", "country": "Russian Federation", "geoPoint": {"lat": 55.0415, "lon": 82.9346}}, {"facility": "Novartis Investigative Site", "city": "Penza", "zip": "440067", "country": "Russian Federation", "geoPoint": {"lat": 53.20066, "lon": 45.00464}}, {"facility": "Novartis Investigative Site", "city": "Petrozavodsk", "zip": "185019", "country": "Russian Federation", "geoPoint": {"lat": 61.78491, "lon": 34.34691}}, {"facility": "Novartis Investigative Site", "city": "Pyatigorsk", "zip": "357538", "country": "Russian Federation", "geoPoint": {"lat": 44.04861, "lon": 43.05944}}, {"facility": "Novartis Investigative Site", "city": "Ryazan", "zip": "390026", "country": "Russian Federation", "geoPoint": {"lat": 54.6269, "lon": 39.6916}}, {"facility": "Novartis Investigative Site", "city": "Ryazan", "zip": "390039", "country": "Russian Federation", "geoPoint": {"lat": 54.6269, "lon": 39.6916}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "191123", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saint-Petersburg", "zip": "192257", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saratov", "zip": "410012", "country": "Russian Federation", "geoPoint": {"lat": 51.54056, "lon": 46.00861}}, {"facility": "Novartis Investigative Site", "city": "Saratov", "zip": "410053", "country": "Russian Federation", "geoPoint": {"lat": 51.54056, "lon": 46.00861}}, {"facility": "Novartis Investigative Site", "city": "Smolensk", "zip": "214006", "country": "Russian Federation", "geoPoint": {"lat": 54.7818, "lon": 32.0401}}, {"facility": "Novartis Investigative Site", "city": "Smolensk", "zip": "214031", "country": "Russian Federation", "geoPoint": {"lat": 54.7818, "lon": 32.0401}}, {"facility": "Novartis Investigative Site", "city": "St Petersburg", "zip": "190044", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St Petersburg", "zip": "191015", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St Petersburg", "zip": "191180", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St Petersburg", "zip": "194223", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St Petersburg", "zip": "194291", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St Petersburg", "zip": "194354", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St-Petersburg", "zip": "193312", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St-Petersburg", "zip": "194291", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St.Petersburg", "zip": "196240", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Stavropol", "zip": "355000", "country": "Russian Federation", "geoPoint": {"lat": 45.0428, "lon": 41.9734}}, {"facility": "Novartis Investigative Site", "city": "Volgograd", "zip": "400120", "country": "Russian Federation", "geoPoint": {"lat": 48.71939, "lon": 44.50183}}, {"facility": "Novartis Investigative Site", "city": "Vologodonsk", "zip": "347382", "country": "Russian Federation"}, {"facility": "Novartis Investigative Site", "city": "Yaroslavl", "zip": "150000", "country": "Russian Federation", "geoPoint": {"lat": 57.62987, "lon": 39.87368}}, {"facility": "Novartis Investigative Site", "city": "Yaroslavl", "zip": "150003", "country": "Russian Federation", "geoPoint": {"lat": 57.62987, "lon": 39.87368}}, {"facility": "Novartis Investigative Site", "city": "Yaroslavl", "zip": "150023", "country": "Russian Federation", "geoPoint": {"lat": 57.62987, "lon": 39.87368}}, {"facility": "Novartis Investigative Site", "city": "Yaroslavl", "zip": "150040", "country": "Russian Federation", "geoPoint": {"lat": 57.62987, "lon": 39.87368}}, {"facility": "Novartis Investigative Site", "city": "Yekaterinburg", "zip": "620137", "country": "Russian Federation", "geoPoint": {"lat": 56.8519, "lon": 60.6122}}, {"facility": "Novartis Investigative Site", "city": "Belgrade", "zip": "11000", "country": "Serbia", "geoPoint": {"lat": 44.80401, "lon": 20.46513}}, {"facility": "Novartis Investigative Site", "city": "Beograd", "zip": "11000", "country": "Serbia"}, {"facility": "Novartis Investigative Site", "city": "Kragujevac", "zip": "34000", "country": "Serbia", "geoPoint": {"lat": 44.01667, "lon": 20.91667}}, {"facility": "Novartis Investigative Site", "city": "Nis", "zip": "18000", "country": "Serbia", "geoPoint": {"lat": 43.32472, "lon": 21.90333}}, {"facility": "Novartis Investigative Site", "city": "Sremska Kamenica", "zip": "21204", "country": "Serbia", "geoPoint": {"lat": 45.22158, "lon": 19.84367}}, {"facility": "Novartis Investigative Site", "city": "Bardejov", "state": "Slovak Republic", "zip": "085 01", "country": "Slovakia", "geoPoint": {"lat": 49.29175, "lon": 21.27271}}, {"facility": "Novartis Investigative Site", "city": "Bojnice", "state": "Slovak Republic", "zip": "972 01", "country": "Slovakia", "geoPoint": {"lat": 48.78511, "lon": 18.5864}}, {"facility": "Novartis Investigative Site", "city": "Bratislava", "state": "Slovak Republic", "zip": "83103", "country": "Slovakia", "geoPoint": {"lat": 48.14816, "lon": 17.10674}}, {"facility": "Novartis Investigative Site", "city": "Humenne", "state": "Slovak Republic", "zip": "066 01", "country": "Slovakia", "geoPoint": {"lat": 48.93707, "lon": 21.91625}}, {"facility": "Novartis Investigative Site", "city": "Kosice", "state": "Slovak Republic", "zip": "040 01", "country": "Slovakia", "geoPoint": {"lat": 48.71395, "lon": 21.25808}}, {"facility": "Novartis Investigative Site", "city": "Nitra", "state": "Slovak Republic", "zip": "949 01", "country": "Slovakia", "geoPoint": {"lat": 48.30763, "lon": 18.08453}}, {"facility": "Novartis Investigative Site", "city": "Skalica", "state": "Slovak Republic", "zip": "90901", "country": "Slovakia", "geoPoint": {"lat": 48.8449, "lon": 17.22635}}, {"facility": "Novartis Investigative Site", "city": "Spisska Nova Ves", "state": "Slovak Republic", "zip": "052 01", "country": "Slovakia", "geoPoint": {"lat": 48.94464, "lon": 20.56153}}, {"facility": "Novartis Investigative Site", "city": "Stropkov", "state": "Slovak Republic", "zip": "09101", "country": "Slovakia", "geoPoint": {"lat": 49.20211, "lon": 21.65216}}, {"facility": "Novartis Investigative Site", "city": "Surany", "state": "Slovak Republic", "zip": "942 01", "country": "Slovakia", "geoPoint": {"lat": 48.08613, "lon": 18.18447}}, {"facility": "Novartis Investigative Site", "city": "Velky Meder", "state": "Slovak Republic", "zip": "94201", "country": "Slovakia", "geoPoint": {"lat": 47.85798, "lon": 17.76884}}, {"facility": "Novartis Investigative Site", "city": "N\u00e1mestovo", "state": "Slovensko", "zip": "02901", "country": "Slovakia", "geoPoint": {"lat": 49.4079, "lon": 19.48032}}, {"facility": "Novartis Investigative Site", "city": "Poprad", "state": "SVK", "zip": "058 01", "country": "Slovakia", "geoPoint": {"lat": 49.06144, "lon": 20.29798}}, {"facility": "Novartis Investigative Site", "city": "Bardejov", "zip": "085 01", "country": "Slovakia", "geoPoint": {"lat": 49.29175, "lon": 21.27271}}, {"facility": "Novartis Investigative Site", "city": "Bratislava", "zip": "85101", "country": "Slovakia", "geoPoint": {"lat": 48.14816, "lon": 17.10674}}, {"facility": "Novartis Investigative Site", "city": "Cadca", "zip": "022 01", "country": "Slovakia", "geoPoint": {"lat": 49.43503, "lon": 18.78895}}, {"facility": "Novartis Investigative Site", "city": "Ilava", "zip": "1901", "country": "Slovakia", "geoPoint": {"lat": 48.99769, "lon": 18.2353}}, {"facility": "Novartis Investigative Site", "city": "Komarno", "zip": "945 01", "country": "Slovakia", "geoPoint": {"lat": 47.76356, "lon": 18.12263}}, {"facility": "Novartis Investigative Site", "city": "Kosice", "zip": "040 01", "country": "Slovakia", "geoPoint": {"lat": 48.71395, "lon": 21.25808}}, {"facility": "Novartis Investigative Site", "city": "Kosice", "zip": "04001", "country": "Slovakia", "geoPoint": {"lat": 48.71395, "lon": 21.25808}}, {"facility": "Novartis Investigative Site", "city": "Kralovsky Chlmec", "zip": "077 01", "country": "Slovakia", "geoPoint": {"lat": 48.42336, "lon": 21.97944}}, {"facility": "Novartis Investigative Site", "city": "Levice", "zip": "034 01", "country": "Slovakia", "geoPoint": {"lat": 48.21563, "lon": 18.60705}}, {"facility": "Novartis Investigative Site", "city": "Liptovsky Mikulas", "zip": "031 23", "country": "Slovakia", "geoPoint": {"lat": 49.08061, "lon": 19.62218}}, {"facility": "Novartis Investigative Site", "city": "Presov", "zip": "080 01", "country": "Slovakia", "geoPoint": {"lat": 48.99839, "lon": 21.23393}}, {"facility": "Novartis Investigative Site", "city": "Prievidza", "zip": "97101", "country": "Slovakia", "geoPoint": {"lat": 48.77446, "lon": 18.6275}}, {"facility": "Novartis Investigative Site", "city": "Topolcany", "zip": "95501", "country": "Slovakia", "geoPoint": {"lat": 48.56361, "lon": 18.16712}}, {"facility": "Novartis Investigative Site", "city": "Zilina", "zip": "010 01", "country": "Slovakia", "geoPoint": {"lat": 49.22315, "lon": 18.73941}}, {"facility": "Novartis Investigative Site", "city": "Zilina", "zip": "01001", "country": "Slovakia", "geoPoint": {"lat": 49.22315, "lon": 18.73941}}, {"facility": "Novartis Investigative Site", "city": "Berea", "state": "Durban", "zip": "4001", "country": "South Africa", "geoPoint": {"lat": -29.85185, "lon": 30.99337}}, {"facility": "Novartis Investigative Site", "city": "Panorama", "state": "Western Cape", "zip": "7500", "country": "South Africa", "geoPoint": {"lat": -25.61314, "lon": 30.52899}}, {"facility": "Novartis Investigative Site", "city": "Belleville", "zip": "7530", "country": "South Africa"}, {"facility": "Novartis Investigative Site", "city": "Cape Town", "zip": "7531", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "Novartis Investigative Site", "city": "Cape Town", "zip": "7700", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "Novartis Investigative Site", "city": "Cape Town", "zip": "7925", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "Novartis Investigative Site", "city": "Fowey", "state": "Cornwall", "zip": "PL23 1DT", "country": "United Kingdom", "geoPoint": {"lat": 50.33634, "lon": -4.6386}}, {"facility": "Novartis Investigative Site", "city": "Liskeard", "state": "Cornwall", "zip": "PL14 3XA", "country": "United Kingdom", "geoPoint": {"lat": 50.4545, "lon": -4.46517}}, {"facility": "Novartis Investigative Site", "city": "Torpoint", "state": "Cornwall", "zip": "PL11 2TB", "country": "United Kingdom", "geoPoint": {"lat": 50.37505, "lon": -4.19566}}, {"facility": "Novartis Investigative Site", "city": "Faringdon", "state": "Oxfordshire", "zip": "SN7 7YU", "country": "United Kingdom", "geoPoint": {"lat": 51.65644, "lon": -1.58676}}, {"facility": "Novartis Investigative Site", "city": "Bristol", "state": "South Gloucestershire", "zip": "BS37 4AX", "country": "United Kingdom", "geoPoint": {"lat": 51.45523, "lon": -2.59665}}, {"facility": "Novartis Investigative Site", "city": "Blackpool", "zip": "FY5 3LF", "country": "United Kingdom", "geoPoint": {"lat": 53.81667, "lon": -3.05}}, {"facility": "Novartis Investigative Site", "city": "Denbighshire", "zip": "LL181DA", "country": "United Kingdom"}, {"facility": "Novartis Investigative Site", "city": "Glasgow", "zip": "G20 0XA", "country": "United Kingdom", "geoPoint": {"lat": 55.86515, "lon": -4.25763}}, {"facility": "Novartis Investigative Site", "city": "London", "zip": "EC14 7BE", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}, {"facility": "Novartis Investigative Site", "city": "London", "zip": "SE5 8AD", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}, {"facility": "Novartis Investigative Site", "city": "Rotherham", "zip": "S65 1DA", "country": "United Kingdom", "geoPoint": {"lat": 53.43012, "lon": -1.35678}}, {"facility": "Novartis Investigative Site", "city": "Wiltshire", "zip": "SN15 2SB", "country": "United Kingdom"}]}, "referencesModule": {"references": [{"pmid": "34452934", "type": "DERIVED", "citation": "Chapman K, van Zyl-Smit R, Maspero J, Kerstjens HAM, Gon Y, Hosoe M, Tanase AM, Pethe A, Shu X, D'Andrea P. One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies. BMJ Open Respir Res. 2021 Aug;8(1):e000819. doi: 10.1136/bmjresp-2020-000819."}, {"pmid": "32653075", "type": "DERIVED", "citation": "van Zyl-Smit RN, Krull M, Gessner C, Gon Y, Noga O, Richard A, de Los Reyes A, Shu X, Pethe A, Tanase AM, D'Andrea P; PALLADIUM trial investigators. Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study. Lancet Respir Med. 2020 Oct;8(10):987-999. doi: 10.1016/S2213-2600(20)30178-8. Epub 2020 Jul 9."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "3890 participants were screened of which 2216 were randomized to 1 of the 5 treatment groups with a randomization ratio of 1:1:1:1:1.", "recruitmentDetails": "Participants took part in 316 investigative sites in 24 countries from 29 Dec 2015 to 28 Jun 2019.", "groups": [{"id": "FG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered once daily (o.d.) via Concept1 inhaler in the evening."}, {"id": "FG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "FG002", "title": "MF 800 \u03bcg", "description": "Mometasone furoate (MF) 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "FG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "FG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "445"}, {"groupId": "FG001", "numSubjects": "439"}, {"groupId": "FG002", "numSubjects": "442"}, {"groupId": "FG003", "numSubjects": "444"}, {"groupId": "FG004", "numSubjects": "446"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "410"}, {"groupId": "FG001", "numSubjects": "413"}, {"groupId": "FG002", "numSubjects": "412"}, {"groupId": "FG003", "numSubjects": "403"}, {"groupId": "FG004", "numSubjects": "416"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "35"}, {"groupId": "FG001", "numSubjects": "26"}, {"groupId": "FG002", "numSubjects": "30"}, {"groupId": "FG003", "numSubjects": "41"}, {"groupId": "FG004", "numSubjects": "30"}]}], "dropWithdraws": [{"type": "Subject/guardian decision", "reasons": [{"groupId": "FG000", "numSubjects": "29"}, {"groupId": "FG001", "numSubjects": "17"}, {"groupId": "FG002", "numSubjects": "18"}, {"groupId": "FG003", "numSubjects": "30"}, {"groupId": "FG004", "numSubjects": "20"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "2"}]}, {"type": "Protocol deviation", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "3"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "2"}]}, {"type": "Technical problems", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "1"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "2"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}]}, {"type": "Non-compliance with study treatment", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "1"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "1"}]}, {"type": "Pregnancy", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Randomized Set (RAN) consisted of all participants who were assigned a randomization number, regardless of whether or not they actually received study medication.", "groups": [{"id": "BG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "BG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "BG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "BG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "BG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}, {"id": "BG005", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "445"}, {"groupId": "BG001", "value": "439"}, {"groupId": "BG002", "value": "442"}, {"groupId": "BG003", "value": "444"}, {"groupId": "BG004", "value": "446"}, {"groupId": "BG005", "value": "2216"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "47.1", "spread": "14.56"}, {"groupId": "BG001", "value": "47.4", "spread": "14.76"}, {"groupId": "BG002", "value": "47.5", "spread": "14.99"}, {"groupId": "BG003", "value": "48.7", "spread": "14.98"}, {"groupId": "BG004", "value": "48.9", "spread": "14.59"}, {"groupId": "BG005", "value": "47.9", "spread": "14.78"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "262"}, {"groupId": "BG001", "value": "253"}, {"groupId": "BG002", "value": "250"}, {"groupId": "BG003", "value": "272"}, {"groupId": "BG004", "value": "256"}, {"groupId": "BG005", "value": "1293"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "183"}, {"groupId": "BG001", "value": "186"}, {"groupId": "BG002", "value": "192"}, {"groupId": "BG003", "value": "172"}, {"groupId": "BG004", "value": "190"}, {"groupId": "BG005", "value": "923"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Race", "categories": [{"title": "Caucasian", "measurements": [{"groupId": "BG000", "value": "313"}, {"groupId": "BG001", "value": "311"}, {"groupId": "BG002", "value": "318"}, {"groupId": "BG003", "value": "312"}, {"groupId": "BG004", "value": "305"}, {"groupId": "BG005", "value": "1559"}]}, {"title": "Black", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "4"}, {"groupId": "BG003", "value": "8"}, {"groupId": "BG004", "value": "4"}, {"groupId": "BG005", "value": "23"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "97"}, {"groupId": "BG001", "value": "98"}, {"groupId": "BG002", "value": "98"}, {"groupId": "BG003", "value": "98"}, {"groupId": "BG004", "value": "102"}, {"groupId": "BG005", "value": "493"}]}, {"title": "Native American", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "11"}, {"groupId": "BG003", "value": "18"}, {"groupId": "BG004", "value": "12"}, {"groupId": "BG005", "value": "68"}]}, {"title": "Pacific Islander", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "1"}]}, {"title": "Other", "measurements": [{"groupId": "BG000", "value": "16"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "11"}, {"groupId": "BG003", "value": "8"}, {"groupId": "BG004", "value": "23"}, {"groupId": "BG005", "value": "72"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Ethnicity", "categories": [{"title": "Hispanic Or Latino", "measurements": [{"groupId": "BG000", "value": "21"}, {"groupId": "BG001", "value": "17"}, {"groupId": "BG002", "value": "14"}, {"groupId": "BG003", "value": "22"}, {"groupId": "BG004", "value": "15"}, {"groupId": "BG005", "value": "89"}]}, {"title": "East Asian", "measurements": [{"groupId": "BG000", "value": "52"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "51"}, {"groupId": "BG003", "value": "55"}, {"groupId": "BG004", "value": "53"}, {"groupId": "BG005", "value": "259"}]}, {"title": "Southeast Asian", "measurements": [{"groupId": "BG000", "value": "38"}, {"groupId": "BG001", "value": "40"}, {"groupId": "BG002", "value": "42"}, {"groupId": "BG003", "value": "38"}, {"groupId": "BG004", "value": "42"}, {"groupId": "BG005", "value": "200"}]}, {"title": "South Asian", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "2"}, {"groupId": "BG003", "value": "3"}, {"groupId": "BG004", "value": "3"}, {"groupId": "BG005", "value": "14"}]}, {"title": "Russian", "measurements": [{"groupId": "BG000", "value": "79"}, {"groupId": "BG001", "value": "79"}, {"groupId": "BG002", "value": "64"}, {"groupId": "BG003", "value": "62"}, {"groupId": "BG004", "value": "65"}, {"groupId": "BG005", "value": "349"}]}, {"title": "Mixed ethnicity", "measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "9"}, {"groupId": "BG003", "value": "5"}, {"groupId": "BG004", "value": "15"}, {"groupId": "BG005", "value": "49"}]}, {"title": "Not reported", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "12"}, {"groupId": "BG003", "value": "5"}, {"groupId": "BG004", "value": "9"}, {"groupId": "BG005", "value": "42"}]}, {"title": "Unknown", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "13"}, {"groupId": "BG002", "value": "6"}, {"groupId": "BG003", "value": "15"}, {"groupId": "BG004", "value": "17"}, {"groupId": "BG005", "value": "63"}]}, {"title": "Other", "measurements": [{"groupId": "BG000", "value": "218"}, {"groupId": "BG001", "value": "225"}, {"groupId": "BG002", "value": "242"}, {"groupId": "BG003", "value": "239"}, {"groupId": "BG004", "value": "227"}, {"groupId": "BG005", "value": "1151"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Trough Forced Expiratory Volume in One Second (Trough FEV1) at Week 26", "description": "Trough FEV1 was assessed by performing spirometric assessment. It is defined as average of the two FEV1 measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "populationDescription": "Full Analysis Set (FAS) consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "litre (L)", "timeFrame": "26 weeks", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "395"}, {"groupId": "OG001", "value": "389"}, {"groupId": "OG002", "value": "372"}, {"groupId": "OG003", "value": "376"}, {"groupId": "OG004", "value": "391"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.383", "spread": "0.0159"}, {"groupId": "OG001", "value": "2.387", "spread": "0.0160"}, {"groupId": "OG002", "value": "2.250", "spread": "0.0162"}, {"groupId": "OG003", "value": "2.176", "spread": "0.0162"}, {"groupId": "OG004", "value": "2.346", "spread": "0.0160"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Mixed Model for Repeated Measures (MMRM)", "paramType": "Least Square mean (LS Mean)", "paramValue": "0.132", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.088", "ciUpperLimit": "0.176", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0223"}, {"groupIds": ["OG001", "OG003"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.211", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.167", "ciUpperLimit": "0.255", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0224"}]}, {"type": "SECONDARY", "title": "Asthma Control Questionnaire (ACQ-7) at Weeks 4, 12, 26 and 52", "description": "The ACQ-7 measured asthma symptom control and consists of 7 items: 5 on symptom assessment, 1 on rescue bronchodilator use and 1 on airway calibre (FEV1 % predicted). All 7 questions of the ACQ-7 were equally weighted. Items 1-5 were scored along a 7-point response scale, where 0 = totally controlled and 6 = severely uncontrolled. Item 6 is scored between 0 = no rescue medication and 6 = More than 16 puffs/inhalations most days. The 7th item was scored by the investigator based on the FEV1 % predicted from the masterscope at the site (i.e., Score = 0 means \\> 95% of predicted FEV1, 1 = 90 - 95%, 2 = 80 - 89%, 3 = 70 - 79%, 4 = 60 - 69%, 5 = 50 - 59%, and Score = 6 means \\< 50% of predicted FEV1). The total score was calculated as the mean of all questions.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication. n represents the number of participants with data at respective visit", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "score on a scale", "timeFrame": "Weeks 4, 12, 26 and 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "429"}, {"groupId": "OG001", "value": "427"}, {"groupId": "OG002", "value": "431"}, {"groupId": "OG003", "value": "428"}, {"groupId": "OG004", "value": "439"}]}], "classes": [{"title": "Week 4", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "426"}, {"groupId": "OG001", "value": "422"}, {"groupId": "OG002", "value": "429"}, {"groupId": "OG003", "value": "425"}, {"groupId": "OG004", "value": "437"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.486", "spread": "0.0337"}, {"groupId": "OG001", "value": "1.533", "spread": "0.0338"}, {"groupId": "OG002", "value": "1.659", "spread": "0.0338"}, {"groupId": "OG003", "value": "1.730", "spread": "0.0337"}, {"groupId": "OG004", "value": "1.541", "spread": "0.0335"}]}]}, {"title": "Week 12", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "419"}, {"groupId": "OG001", "value": "414"}, {"groupId": "OG002", "value": "422"}, {"groupId": "OG003", "value": "407"}, {"groupId": "OG004", "value": "429"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.394", "spread": "0.0347"}, {"groupId": "OG001", "value": "1.377", "spread": "0.0348"}, {"groupId": "OG002", "value": "1.523", "spread": "0.0348"}, {"groupId": "OG003", "value": "1.625", "spread": "0.0350"}, {"groupId": "OG004", "value": "1.445", "spread": "0.0345"}]}]}, {"title": "Week 26", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "407"}, {"groupId": "OG001", "value": "407"}, {"groupId": "OG002", "value": "405"}, {"groupId": "OG003", "value": "393"}, {"groupId": "OG004", "value": "410"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.267", "spread": "0.0350"}, {"groupId": "OG001", "value": "1.261", "spread": "0.0350"}, {"groupId": "OG002", "value": "1.439", "spread": "0.0352"}, {"groupId": "OG003", "value": "1.509", "spread": "0.0354"}, {"groupId": "OG004", "value": "1.322", "spread": "0.0349"}]}]}, {"title": "Week 52", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "385"}, {"groupId": "OG001", "value": "397"}, {"groupId": "OG002", "value": "387"}, {"groupId": "OG003", "value": "377"}, {"groupId": "OG004", "value": "405"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.231", "spread": "0.0358"}, {"groupId": "OG001", "value": "1.183", "spread": "0.0356"}, {"groupId": "OG002", "value": "1.373", "spread": "0.0359"}, {"groupId": "OG003", "value": "1.449", "spread": "0.0361"}, {"groupId": "OG004", "value": "1.221", "spread": "0.0354"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Week 4", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.172", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.254", "ciUpperLimit": "-0.091", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0415"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 4", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.196", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.278", "ciUpperLimit": "-0.115", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0416"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 4", "nonInferiorityType": "SUPERIORITY", "pValue": "0.186", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.055", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.136", "ciUpperLimit": "0.026", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0414"}, {"groupIds": ["OG000", "OG001", "OG002", "OG003"], "groupDescription": "Week 4: The comparison of QMF149 vs. MF was based on combined effects of QMF149 150/160 \\& 150/320 \u03bcg and MF 400 \\& 800 \u03bcg derived by weighting treatment groups equally.", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.184", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.242", "ciUpperLimit": "-0.127", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0294"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 12", "nonInferiorityType": "SUPERIORITY", "pValue": "0.003", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.129", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.214", "ciUpperLimit": "-0.044", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0431"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 12", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.248", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.333", "ciUpperLimit": "-0.162", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0435"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 12", "nonInferiorityType": "SUPERIORITY", "pValue": "0.232", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.052", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.136", "ciUpperLimit": "0.033", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0431"}, {"groupIds": ["OG000", "OG001", "OG002", "OG003"], "groupDescription": "Week 12: The comparison of QMF149 vs. MF was based on combined effects of QMF149 150/160 \\& 150/320 \u03bcg and MF 400 \\& 800 \u03bcg derived by weighting treatment groups equally.", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.188", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.248", "ciUpperLimit": "-0.128", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0307"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 26", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.171", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.257", "ciUpperLimit": "-0.086", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0437"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 26", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.248", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.334", "ciUpperLimit": "-0.162", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0439"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 26", "nonInferiorityType": "SUPERIORITY", "pValue": "0.214", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.054", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.140", "ciUpperLimit": "0.031", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0437"}, {"groupIds": ["OG000", "OG001", "OG002", "OG003"], "groupDescription": "Week 26: The comparison of QMF149 vs. MF was based on combined effects of QMF149 150/160 \\& 150/320 \u03bcg and MF 400 \\& 800 \u03bcg derived by weighting treatment groups equally.", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.209", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.270", "ciUpperLimit": "-0.149", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0310"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 52", "nonInferiorityType": "SUPERIORITY", "pValue": "0.002", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.141", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.229", "ciUpperLimit": "-0.053", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0449"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 52", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.266", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.354", "ciUpperLimit": "-0.177", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.045"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 52", "nonInferiorityType": "SUPERIORITY", "pValue": "0.824", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.01", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.078", "ciUpperLimit": "0.098", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0447"}, {"groupIds": ["OG000", "OG001", "OG002", "OG003"], "groupDescription": "Week 52: The comparison of QMF149 vs. MF was based on combined effects of QMF149 150/160 \\& 150/320 \u03bcg and MF 400 \\& 800 \u03bcg derived by weighting treatment groups equally.", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.203", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.266", "ciUpperLimit": "-0.141", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0318"}]}, {"type": "SECONDARY", "title": "Trough FEV1 at Week 52", "description": "Trough FEV1 was assessed by performing spirometric assessment. It is defined as average of the two FEV1 measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "L", "timeFrame": "Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "372"}, {"groupId": "OG001", "value": "383"}, {"groupId": "OG002", "value": "364"}, {"groupId": "OG003", "value": "369"}, {"groupId": "OG004", "value": "382"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.386", "spread": "0.0168"}, {"groupId": "OG001", "value": "2.357", "spread": "0.0167"}, {"groupId": "OG002", "value": "2.249", "spread": "0.0170"}, {"groupId": "OG003", "value": "2.148", "spread": "0.0170"}, {"groupId": "OG004", "value": "2.338", "spread": "0.0167"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.136", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.090", "ciUpperLimit": "0.183", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0235"}, {"groupIds": ["OG001", "OG003"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.209", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.163", "ciUpperLimit": "0.255", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0235"}, {"groupIds": ["OG000", "OG004"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.04", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.048", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.002", "ciUpperLimit": "0.094", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0234"}]}, {"type": "SECONDARY", "title": "Pre-dose FEV1 at Weeks 4 and 12", "description": "Pre-dose trough FEV1 is defined as average of the two FEV1 measurements taken 45 min and 15 min pre evening dose. It was assessed by performing spirometric assessment. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication. n represents the number of participants with data at respective visit.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "L", "timeFrame": "Weeks 4 (Day 30) and 12 (Day 86)", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d via Twisthaler\u00ae in the evening"}, {"id": "OG004", "title": "Salmeterol /Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "430"}, {"groupId": "OG001", "value": "427"}, {"groupId": "OG002", "value": "430"}, {"groupId": "OG003", "value": "427"}, {"groupId": "OG004", "value": "439"}]}], "classes": [{"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "430"}, {"groupId": "OG001", "value": "424"}, {"groupId": "OG002", "value": "421"}, {"groupId": "OG003", "value": "412"}, {"groupId": "OG004", "value": "435"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.369", "spread": "0.0141"}, {"groupId": "OG001", "value": "2.367", "spread": "0.0142"}, {"groupId": "OG002", "value": "2.237", "spread": "0.0143"}, {"groupId": "OG003", "value": "2.171", "spread": "0.0143"}, {"groupId": "OG004", "value": "0.2333", "spread": "0.0141"}]}]}, {"title": "Day 86", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "414"}, {"groupId": "OG001", "value": "414"}, {"groupId": "OG002", "value": "419"}, {"groupId": "OG003", "value": "398"}, {"groupId": "OG004", "value": "428"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.368", "spread": "0.0148"}, {"groupId": "OG001", "value": "2.361", "spread": "0.0148"}, {"groupId": "OG002", "value": "2.245", "spread": "0.0148"}, {"groupId": "OG003", "value": "2.177", "spread": "0.0149"}, {"groupId": "OG004", "value": "2.330", "spread": "0.0146"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Day 30", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.132", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.094", "ciUpperLimit": "0.170", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0193"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 30", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.196", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.158", "ciUpperLimit": "0.234", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0194"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 30", "nonInferiorityType": "SUPERIORITY", "pValue": "0.064", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.035", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.002", "ciUpperLimit": "0.073", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0192"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 86", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.122", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.083", "ciUpperLimit": "0.162", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0201"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 86", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.184", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.144", "ciUpperLimit": "0.224", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0202"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 86", "nonInferiorityType": "SUPERIORITY", "pValue": "0.063", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.037", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.002", "ciUpperLimit": "0.076", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.02"}]}, {"type": "SECONDARY", "title": "Post Dose FEV1 (5 Minutes-1 Hour)", "description": "Post-dose FEV1 measurements were analyzed at 5 minutes, 15 minutes, 30 minutes and 1 hour. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication. n represents the number of participants with data at respective time point.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "L", "timeFrame": "Up to Week 52 (Day 364)", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "441"}, {"groupId": "OG001", "value": "434"}, {"groupId": "OG002", "value": "438"}, {"groupId": "OG003", "value": "438"}, {"groupId": "OG004", "value": "442"}]}], "classes": [{"title": "Day 1: 5 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "427"}, {"groupId": "OG001", "value": "426"}, {"groupId": "OG002", "value": "429"}, {"groupId": "OG003", "value": "432"}, {"groupId": "OG004", "value": "435"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.279", "spread": "0.0084"}, {"groupId": "OG001", "value": "2.270", "spread": "0.0085"}, {"groupId": "OG002", "value": "2.138", "spread": "0.0085"}, {"groupId": "OG003", "value": "2.118", "spread": "0.0084"}, {"groupId": "OG004", "value": "2.224", "spread": "0.0084"}]}]}, {"title": "Day 1: 15 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "434"}, {"groupId": "OG001", "value": "425"}, {"groupId": "OG002", "value": "433"}, {"groupId": "OG003", "value": "433"}, {"groupId": "OG004", "value": "441"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.321", "spread": "0.0088"}, {"groupId": "OG001", "value": "2.312", "spread": "0.0089"}, {"groupId": "OG002", "value": "2.159", "spread": "0.0089"}, {"groupId": "OG003", "value": "2.137", "spread": "0.0089"}, {"groupId": "OG004", "value": "2.278", "spread": "0.0088"}]}]}, {"title": "Day 1: 30 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "439"}, {"groupId": "OG001", "value": "431"}, {"groupId": "OG002", "value": "434"}, {"groupId": "OG003", "value": "438"}, {"groupId": "OG004", "value": "441"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.338", "spread": "0.0095"}, {"groupId": "OG001", "value": "2.326", "spread": "0.0096"}, {"groupId": "OG002", "value": "2.162", "spread": "0.0096"}, {"groupId": "OG003", "value": "2.141", "spread": "0.0095"}, {"groupId": "OG004", "value": "2.310", "spread": "0.0095"}]}]}, {"title": "Day 1: 1 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "440"}, {"groupId": "OG001", "value": "434"}, {"groupId": "OG002", "value": "435"}, {"groupId": "OG003", "value": "438"}, {"groupId": "OG004", "value": "442"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.343", "spread": "0.0100"}, {"groupId": "OG001", "value": "2.347", "spread": "0.0101"}, {"groupId": "OG002", "value": "2.166", "spread": "0.0101"}, {"groupId": "OG003", "value": "2.142", "spread": "0.0100"}, {"groupId": "OG004", "value": "2.337", "spread": "0.0100"}]}]}, {"title": "Day 30: 5 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "428"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "419"}, {"groupId": "OG003", "value": "411"}, {"groupId": "OG004", "value": "435"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.413", "spread": "0.0142"}, {"groupId": "OG001", "value": "2.406", "spread": "0.0144"}, {"groupId": "OG002", "value": "2.224", "spread": "0.0145"}, {"groupId": "OG003", "value": "2.174", "spread": "0.0145"}, {"groupId": "OG004", "value": "2.360", "spread": "0.0142"}]}]}, {"title": "Day 30: 30 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "429"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "421"}, {"groupId": "OG003", "value": "412"}, {"groupId": "OG004", "value": "435"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.432", "spread": "0.0143"}, {"groupId": "OG001", "value": "2.426", "spread": "0.0145"}, {"groupId": "OG002", "value": "2.238", "spread": "0.0146"}, {"groupId": "OG003", "value": "2.174", "spread": "0.0146"}, {"groupId": "OG004", "value": "2.389", "spread": "0.0143"}]}]}, {"title": "Day 30: 1 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "428"}, {"groupId": "OG001", "value": "416"}, {"groupId": "OG002", "value": "421"}, {"groupId": "OG003", "value": "410"}, {"groupId": "OG004", "value": "435"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.448", "spread": "0.0145"}, {"groupId": "OG001", "value": "2.440", "spread": "0.0146"}, {"groupId": "OG002", "value": "2.257", "spread": "0.0147"}, {"groupId": "OG003", "value": "2.183", "spread": "0.0148"}, {"groupId": "OG004", "value": "2.411", "spread": "0.0144"}]}]}, {"title": "Day 86:5 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "411"}, {"groupId": "OG001", "value": "411"}, {"groupId": "OG002", "value": "416"}, {"groupId": "OG003", "value": "395"}, {"groupId": "OG004", "value": "427"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.411", "spread": "0.0150"}, {"groupId": "OG001", "value": "2.409", "spread": "0.0150"}, {"groupId": "OG002", "value": "2.248", "spread": "0.0150"}, {"groupId": "OG003", "value": "2.178", "spread": "0.0153"}, {"groupId": "OG004", "value": "2.356", "spread": "0.0148"}]}]}, {"title": "Day 86: 30 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "412"}, {"groupId": "OG001", "value": "411"}, {"groupId": "OG002", "value": "417"}, {"groupId": "OG003", "value": "395"}, {"groupId": "OG004", "value": "426"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.436", "spread": "0.0149"}, {"groupId": "OG001", "value": "2.431", "spread": "0.0149"}, {"groupId": "OG002", "value": "2.257", "spread": "0.0149"}, {"groupId": "OG003", "value": "2.179", "spread": "0.0152"}, {"groupId": "OG004", "value": "2.398", "spread": "0.0147"}]}]}, {"title": "Day 86:1 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "412"}, {"groupId": "OG001", "value": "410"}, {"groupId": "OG002", "value": "417"}, {"groupId": "OG003", "value": "396"}, {"groupId": "OG004", "value": "426"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.456", "spread": "0.0151"}, {"groupId": "OG001", "value": "2.436", "spread": "0.0151"}, {"groupId": "OG002", "value": "2.269", "spread": "0.0151"}, {"groupId": "OG003", "value": "2.188", "spread": "0.0154"}, {"groupId": "OG004", "value": "2.413", "spread": "0.0149"}]}]}, {"title": "Day 183: 5 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "404"}, {"groupId": "OG001", "value": "399"}, {"groupId": "OG002", "value": "400"}, {"groupId": "OG003", "value": "385"}, {"groupId": "OG004", "value": "409"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.403", "spread": "0.0160"}, {"groupId": "OG001", "value": "2.406", "spread": "0.0161"}, {"groupId": "OG002", "value": "2.240", "spread": "0.0162"}, {"groupId": "OG003", "value": "2.163", "spread": "0.0164"}, {"groupId": "OG004", "value": "2.359", "spread": "0.0160"}]}]}, {"title": "Day 183: 30 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "405"}, {"groupId": "OG001", "value": "401"}, {"groupId": "OG002", "value": "399"}, {"groupId": "OG003", "value": "383"}, {"groupId": "OG004", "value": "407"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.426", "spread": "0.0163"}, {"groupId": "OG001", "value": "2.427", "spread": "0.0164"}, {"groupId": "OG002", "value": "2.250", "spread": "0.0165"}, {"groupId": "OG003", "value": "2.168", "spread": "0.0167"}, {"groupId": "OG004", "value": "2.386", "spread": "0.0163"}]}]}, {"title": "Day 183: 1 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "405"}, {"groupId": "OG001", "value": "400"}, {"groupId": "OG002", "value": "397"}, {"groupId": "OG003", "value": "385"}, {"groupId": "OG004", "value": "409"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.432", "spread": "0.0161"}, {"groupId": "OG001", "value": "2.423", "spread": "0.0162"}, {"groupId": "OG002", "value": "2.253", "spread": "0.0163"}, {"groupId": "OG003", "value": "2.165", "spread": "0.0165"}, {"groupId": "OG004", "value": "2.393", "spread": "0.0161"}]}]}, {"title": "Day 364: 5 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "375"}, {"groupId": "OG001", "value": "389"}, {"groupId": "OG002", "value": "380"}, {"groupId": "OG003", "value": "374"}, {"groupId": "OG004", "value": "403"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.384", "spread": "0.0172"}, {"groupId": "OG001", "value": "2.379", "spread": "0.0169"}, {"groupId": "OG002", "value": "2.245", "spread": "0.0172"}, {"groupId": "OG003", "value": "2.130", "spread": "0.0173"}, {"groupId": "OG004", "value": "2.358", "spread": "0.0168"}]}]}, {"title": "Day 364: 30 minutes", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "377"}, {"groupId": "OG001", "value": "393"}, {"groupId": "OG002", "value": "379"}, {"groupId": "OG003", "value": "373"}, {"groupId": "OG004", "value": "401"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.408", "spread": "0.0171"}, {"groupId": "OG001", "value": "2.399", "spread": "0.0169"}, {"groupId": "OG002", "value": "2.253", "spread": "0.0172"}, {"groupId": "OG003", "value": "2.135", "spread": "0.0172"}, {"groupId": "OG004", "value": "2.377", "spread": "0.0167"}]}]}, {"title": "Day 364:1 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "378"}, {"groupId": "OG001", "value": "393"}, {"groupId": "OG002", "value": "379"}, {"groupId": "OG003", "value": "375"}, {"groupId": "OG004", "value": "402"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.414", "spread": "0.0175"}, {"groupId": "OG001", "value": "2.390", "spread": "0.0172"}, {"groupId": "OG002", "value": "2.251", "spread": "0.0175"}, {"groupId": "OG003", "value": "2.128", "spread": "0.0176"}, {"groupId": "OG004", "value": "2.383", "spread": "0.0171"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Day 1: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.142", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.119", "ciUpperLimit": "0.164", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0116"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 1: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.152", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.129", "ciUpperLimit": "0.175", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0116"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 1: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.055", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.032", "ciUpperLimit": "0.078", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0116"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 1: 15 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.162", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.138", "ciUpperLimit": "0.186", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0122"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 1: 15 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<.001", "statisticalMethod": "MMRM", "paramType": "LS mean", "paramValue": "0.174", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.150", "ciUpperLimit": "0.198", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0123"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day1: 15 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.044", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.02", "ciUpperLimit": "0.068", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0122"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 1: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.175", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.149", "ciUpperLimit": "0.201", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0132"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 1: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.185", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.159", "ciUpperLimit": "0.211", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0132"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 1: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "0.038", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.027", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.001", "ciUpperLimit": "0.053", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0132"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 1: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.178", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.150", "ciUpperLimit": "0.205", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0139"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 1: 1hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.205", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.177", "ciUpperLimit": "0.232", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0139"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 1: 1hour", "nonInferiorityType": "SUPERIORITY", "pValue": "0.632", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.007", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.021", "ciUpperLimit": "0.034", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0139"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 30: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.189", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.151", "ciUpperLimit": "0.226", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0192"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 30: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.232", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.194", "ciUpperLimit": "0.270", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0194"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 30: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "0.005", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.053", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.016", "ciUpperLimit": "0.091", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0191"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 30: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.194", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.156", "ciUpperLimit": "0.232", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0194"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 30: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.253", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.214", "ciUpperLimit": "0.291", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0196"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 30: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "0.026", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.043", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.005", "ciUpperLimit": "0.08", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0192"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 30: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.190", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.152", "ciUpperLimit": "0.229", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0196"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 30: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.258", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.219", "ciUpperLimit": "0.296", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0198"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 30: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "0.059", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.037", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.001", "ciUpperLimit": "0.075", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0194"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 86: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.163", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.123", "ciUpperLimit": "0.203", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0204"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 86: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.231", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.191", "ciUpperLimit": "0.271", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0206"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 86: 5minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "0.007", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.055", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.015", "ciUpperLimit": "0.095", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0203"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 86: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.180", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.140", "ciUpperLimit": "0.219", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0203"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 86: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.252", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.211", "ciUpperLimit": "0.292", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0205"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 86: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "0.057", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.038", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.001", "ciUpperLimit": "0.078", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0202"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 86: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.187", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.147", "ciUpperLimit": "0.227", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0205"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 86: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.249", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.208", "ciUpperLimit": "0.289", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0208"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 86: 1hour", "nonInferiorityType": "SUPERIORITY", "pValue": "0.037", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.043", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.003", "ciUpperLimit": "0.083", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0205"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 183: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.163", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.121", "ciUpperLimit": "0.206", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0217"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 183: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.243", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.200", "ciUpperLimit": "0.286", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0219"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 183: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "0.041", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.044", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.002", "ciUpperLimit": "0.087", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0216"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 183: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.176", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.133", "ciUpperLimit": "0.220", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0222"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 183: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.259", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.215", "ciUpperLimit": "0.303", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0224"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 183: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "0.071", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.04", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.003", "ciUpperLimit": "0.083", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0221"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 183: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.180", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.137", "ciUpperLimit": "0.223", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0219"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 183: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.259", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.215", "ciUpperLimit": "0.302", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0222"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 183: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "0.071", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.039", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.003", "ciUpperLimit": "0.082", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0218"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 364: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.139", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.094", "ciUpperLimit": "0.184", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0229"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 364: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.249", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.205", "ciUpperLimit": "0.294", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0228"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 364: 5 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "0.244", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.026", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.018", "ciUpperLimit": "0.071", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0227"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 364: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.155", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.110", "ciUpperLimit": "0.200", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0228"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 364: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.264", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.219", "ciUpperLimit": "0.308", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0227"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 364: 30 minutes", "nonInferiorityType": "SUPERIORITY", "pValue": "0.162", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.032", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.013", "ciUpperLimit": "0.076", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0226"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 364: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.163", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.117", "ciUpperLimit": "0.209", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0234"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 364: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.262", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.216", "ciUpperLimit": "0.308", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0232"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 364: 1 hour", "nonInferiorityType": "SUPERIORITY", "pValue": "0.182", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.031", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.014", "ciUpperLimit": "0.076", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0231"}]}, {"type": "SECONDARY", "title": "Trough Forced Vital Capacity (FVC)", "description": "FVC is the total amount of air exhaled during the FEV test. Trough FVC is defined as average of the two FVC measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. It was assessed by performing spirometric assessment.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication. n represents the number of participants with data at respective visit.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "L", "timeFrame": "Up to Week 52 (Day 365)", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "439"}, {"groupId": "OG001", "value": "433"}, {"groupId": "OG002", "value": "436"}, {"groupId": "OG003", "value": "441"}, {"groupId": "OG004", "value": "441"}]}], "classes": [{"title": "Day 2", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "432"}, {"groupId": "OG001", "value": "430"}, {"groupId": "OG002", "value": "410"}, {"groupId": "OG003", "value": "435"}, {"groupId": "OG004", "value": "419"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "3.342", "spread": "0.0173"}, {"groupId": "OG001", "value": "3.342", "spread": "0.0174"}, {"groupId": "OG002", "value": "3.256", "spread": "0.0177"}, {"groupId": "OG003", "value": "3.203", "spread": "0.0173"}, {"groupId": "OG004", "value": "3.344", "spread": "0.0176"}]}]}, {"title": "Day 184", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "395"}, {"groupId": "OG001", "value": "389"}, {"groupId": "OG002", "value": "372"}, {"groupId": "OG003", "value": "376"}, {"groupId": "OG004", "value": "391"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "3.372", "spread": "0.0179"}, {"groupId": "OG001", "value": "3.387", "spread": "0.0180"}, {"groupId": "OG002", "value": "3.322", "spread": "0.0183"}, {"groupId": "OG003", "value": "3.246", "spread": "0.0182"}, {"groupId": "OG004", "value": "3.355", "spread": "0.0180"}]}]}, {"title": "Day 365", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "372"}, {"groupId": "OG001", "value": "383"}, {"groupId": "OG002", "value": "365"}, {"groupId": "OG003", "value": "369"}, {"groupId": "OG004", "value": "382"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "3.394", "spread": "0.0182"}, {"groupId": "OG001", "value": "3.364", "spread": "0.0181"}, {"groupId": "OG002", "value": "3.319", "spread": "0.0184"}, {"groupId": "OG003", "value": "3.218", "spread": "0.0183"}, {"groupId": "OG004", "value": "3.358", "spread": "0.0182"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Day 2", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.086", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.040", "ciUpperLimit": "0.133", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0237"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 2", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.139", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.093", "ciUpperLimit": "0.185", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0235"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 2", "nonInferiorityType": "SUPERIORITY", "pValue": "0.927", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.002", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.049", "ciUpperLimit": "0.044", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0237"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 184", "nonInferiorityType": "SUPERIORITY", "pValue": "0.044", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.050", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.001", "ciUpperLimit": "0.098", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0246"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 184", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.141", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.093", "ciUpperLimit": "0.190", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0246"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 184", "nonInferiorityType": "SUPERIORITY", "pValue": "0.490", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.017", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.031", "ciUpperLimit": "0.065", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0244"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 365", "nonInferiorityType": "SUPERIORITY", "pValue": "0.002", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.076", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.027", "ciUpperLimit": "0.125", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0249"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 365", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.146", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.098", "ciUpperLimit": "0.195", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0248"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 365", "nonInferiorityType": "SUPERIORITY", "pValue": "0.143", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.036", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.012", "ciUpperLimit": "0.085", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0248"}]}, {"type": "SECONDARY", "title": "Trough Forced Expiratory Flow (FEF)Between 25% and 75% of FVC (FEF25-75)", "description": "FEF is the flow (or speed) of air coming out of the lung during the middle portion of a forced expiration. Trough FEF25-75% is defined as average of the two FEF25-75% measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. It was assessed by performing spirometric assessment.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication. n represents the number of participants with data at respective visit.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Litres/second (L/s)", "timeFrame": "Up to Week 52 (Day 365)", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "439"}, {"groupId": "OG001", "value": "433"}, {"groupId": "OG002", "value": "436"}, {"groupId": "OG003", "value": "441"}, {"groupId": "OG004", "value": "441"}]}], "classes": [{"title": "Day 2", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "432"}, {"groupId": "OG001", "value": "430"}, {"groupId": "OG002", "value": "410"}, {"groupId": "OG003", "value": "435"}, {"groupId": "OG004", "value": "419"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.644", "spread": "0.0186"}, {"groupId": "OG001", "value": "1.617", "spread": "0.0187"}, {"groupId": "OG002", "value": "1.455", "spread": "0.0191"}, {"groupId": "OG003", "value": "1.406", "spread": "0.0186"}, {"groupId": "OG004", "value": "1.662", "spread": "0.0189"}]}]}, {"title": "Day 184", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "395"}, {"groupId": "OG001", "value": "389"}, {"groupId": "OG002", "value": "372"}, {"groupId": "OG003", "value": "376"}, {"groupId": "OG004", "value": "391"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.775", "spread": "0.0249"}, {"groupId": "OG001", "value": "1.738", "spread": "0.0250"}, {"groupId": "OG002", "value": "1.546", "spread": "0.0253"}, {"groupId": "OG003", "value": "1.473", "spread": "0.0254"}, {"groupId": "OG004", "value": "1.692", "spread": "0.0250"}]}]}, {"title": "Day 365", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "372"}, {"groupId": "OG001", "value": "383"}, {"groupId": "OG002", "value": "365"}, {"groupId": "OG003", "value": "369"}, {"groupId": "OG004", "value": "382"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.745", "spread": "0.0259"}, {"groupId": "OG001", "value": "1.686", "spread": "0.0257"}, {"groupId": "OG002", "value": "1.530", "spread": "0.0261"}, {"groupId": "OG003", "value": "1.440", "spread": "0.0261"}, {"groupId": "OG004", "value": "1.692", "spread": "0.0258"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Day 2", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.189", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.139", "ciUpperLimit": "0.238", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0253"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 2", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.210", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.161", "ciUpperLimit": "0.259", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.025"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 2", "nonInferiorityType": "SUPERIORITY", "pValue": "0.475", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.018", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.067", "ciUpperLimit": "0.031", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0252"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 184", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.228", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.161", "ciUpperLimit": "0.296", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0345"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 184", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.265", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.197", "ciUpperLimit": "0.333", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0346"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 184", "nonInferiorityType": "SUPERIORITY", "pValue": "0.015", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.083", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.016", "ciUpperLimit": "0.151", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0343"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 365", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.215", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.145", "ciUpperLimit": "0.285", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0358"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 365", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.246", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.176", "ciUpperLimit": "0.316", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0357"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 365", "nonInferiorityType": "SUPERIORITY", "pValue": "0.139", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.053", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.017", "ciUpperLimit": "0.122", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0356"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Morning and Evening Peak Expiratory Flow Rate (PEF) Over 26 and 52 Weeks of Treatment", "description": "PEF is a person's maximum speed of expiration. All the participants were instructed to record PEF twice daily using a mini Peak Flow Meter device, once in the morning (before taking the morning dose) and once approximately 12 h later in the evening (before taking the evening dose). At each timepoint, the participant was instructed to perform 3 consecutive manoeuvres within 10 minutes. These PEF values were captured in the e-PEF/diary. The best of 3 values were used.", "populationDescription": "Full Analysis Set (FAS) consisted of all patients in the RAN set who received at least one dose of study medication. n represents tthe number of participants with data at respective visit.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "L/min", "timeFrame": "Up to Weeks 26 and 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"title": "Week 26: Mean morning PEF", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "418"}, {"groupId": "OG001", "value": "419"}, {"groupId": "OG002", "value": "430"}, {"groupId": "OG003", "value": "422"}, {"groupId": "OG004", "value": "426"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "42.4", "spread": "2.15"}, {"groupId": "OG001", "value": "38.1", "spread": "2.15"}, {"groupId": "OG002", "value": "12.8", "spread": "2.13"}, {"groupId": "OG003", "value": "5.9", "spread": "2.14"}, {"groupId": "OG004", "value": "29.1", "spread": "2.14"}]}]}, {"title": "Week 26:Mean evening PEF", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "417"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "425"}, {"groupId": "OG003", "value": "419"}, {"groupId": "OG004", "value": "423"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "32.5", "spread": "2.05"}, {"groupId": "OG001", "value": "30.4", "spread": "2.04"}, {"groupId": "OG002", "value": "7.7", "spread": "2.04"}, {"groupId": "OG003", "value": "0.0", "spread": "2.05"}, {"groupId": "OG004", "value": "23.9", "spread": "2.04"}]}]}, {"title": "Week 52:Mean morning PEF", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "415"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "427"}, {"groupId": "OG003", "value": "422"}, {"groupId": "OG004", "value": "424"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "42.1", "spread": "2.24"}, {"groupId": "OG001", "value": "36.9", "spread": "2.22"}, {"groupId": "OG002", "value": "13.4", "spread": "2.21"}, {"groupId": "OG003", "value": "6.7", "spread": "2.22"}, {"groupId": "OG004", "value": "28.3", "spread": "2.22"}]}]}, {"title": "Week 52:Mean evening PEF", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "416"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "424"}, {"groupId": "OG003", "value": "418"}, {"groupId": "OG004", "value": "422"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "31.2", "spread": "2.14"}, {"groupId": "OG001", "value": "28.7", "spread": "2.13"}, {"groupId": "OG002", "value": "7.4", "spread": "2.13"}, {"groupId": "OG003", "value": "-0.3", "spread": "2.14"}, {"groupId": "OG004", "value": "22.1", "spread": "2.13"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Week 26: Mean morning PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Linear Mixed Model (LMM)", "paramType": "LS Mean", "paramValue": "29.6", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "23.8", "ciUpperLimit": "35.4", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.96"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 26: Mean morning PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "32.2", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "26.4", "ciUpperLimit": "38.1", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.97"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 26: Mean morning PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "13.3", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "7.5", "ciUpperLimit": "19.1", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.97"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 26: Mean evening PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "24.8", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "19.3", "ciUpperLimit": "30.3", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.82"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 26: Mean evening PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "30.4", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "24.8", "ciUpperLimit": "35.9", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.83"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 26: Mean evening PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "0.002", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "8.6", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "3.1", "ciUpperLimit": "14.2", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.83"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 52: Mean morning PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "28.7", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "22.7", "ciUpperLimit": "34.8", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "3.07"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 52: Mean morning PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "30.2", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "24.2", "ciUpperLimit": "36.3", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "3.07"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 52: Mean morning PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "13.8", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "7.7", "ciUpperLimit": "19.8", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "3.08"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 52: Mean evening PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "23.7", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "18.0", "ciUpperLimit": "29.5", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.94"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 52: Mean evening PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "29.1", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "23.3", "ciUpperLimit": "34.8", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.94"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 52: Mean evening PEF", "nonInferiorityType": "SUPERIORITY", "pValue": "0.002", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "9.1", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "3.3", "ciUpperLimit": "14.9", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.95"}]}, {"type": "SECONDARY", "title": "Percentage of Participants Achieving the Minimal Important Difference (MID) ACQ \u2265 0.5 at Weeks 26 and 52", "description": "Change from baseline in ACQ-7 scores of \u2264 0.5 was defined as minimal clinically important difference and were considered clinically meaningful. The ACQ-7 measured asthma symptom control and consists of 7 items: 5 on symptom assessment, 1 on rescue bronchodilator use and 1 on airway calibre (FEV1 % predicted). All 7 questions of the ACQ-7 were equally weighted. Items 1-5 were scored along a 7-point response scale, where 0 = totally controlled and 6 = severely uncontrolled. Item 6 is scored between 0 = no rescue medication and 6 = More than 16 puffs/inhalations most days. The 7th item was scored by the investigator based on the FEV1 % predicted from the masterscope at the site (i.e., Score = 0 means \\> 95% of predicted FEV1, 1 = 90 - 95%, 2 = 80 - 89%, 3 = 70 - 79%, 4 = 60 - 69%, 5 = 50 - 59%, and Score = 6 means \\< 50% of predicted FEV1). The total score was calculated as the mean of all questions", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication. n represents number of participants with data at the respective visit.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "Weeks 26 (Day 183) and 52 (Day 364)", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "442"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"title": "Day 183", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "407"}, {"groupId": "OG001", "value": "407"}, {"groupId": "OG002", "value": "405"}, {"groupId": "OG003", "value": "393"}, {"groupId": "OG004", "value": "410"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "76.4"}, {"groupId": "OG001", "value": "76.2"}, {"groupId": "OG002", "value": "72.3"}, {"groupId": "OG003", "value": "66.9"}, {"groupId": "OG004", "value": "75.9"}]}]}, {"title": "Day 364", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "385"}, {"groupId": "OG001", "value": "397"}, {"groupId": "OG002", "value": "387"}, {"groupId": "OG003", "value": "377"}, {"groupId": "OG004", "value": "405"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "77.7"}, {"groupId": "OG001", "value": "82.1"}, {"groupId": "OG002", "value": "73.6"}, {"groupId": "OG003", "value": "69.2"}, {"groupId": "OG004", "value": "77.3"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001", "OG002"], "groupDescription": "Day 183", "nonInferiorityType": "SUPERIORITY", "pValue": "0.094", "statisticalMethod": "Logistic regression model", "paramType": "Odds Ratio (OR)", "paramValue": "1.31", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.95", "ciUpperLimit": "1.81"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 183", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Logistic regression model", "paramType": "Odds Ratio (OR)", "paramValue": "1.73", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.26", "ciUpperLimit": "2.37"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 183", "nonInferiorityType": "SUPERIORITY", "pValue": "0.746", "statisticalMethod": "Logistic regression model", "paramType": "Odds Ratio (OR)", "paramValue": "1.06", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.76", "ciUpperLimit": "1.46"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 364", "nonInferiorityType": "SUPERIORITY", "pValue": "0.088", "statisticalMethod": "Logistic regression model", "paramType": "Odds Ratio (OR)", "paramValue": "1.34", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.96", "ciUpperLimit": "1.87"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 364", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Logistic regression model", "paramType": "Odds Ratio (OR)", "paramValue": "2.24", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.58", "ciUpperLimit": "3.17"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 364", "nonInferiorityType": "SUPERIORITY", "pValue": "0.771", "statisticalMethod": "Logistic regression model", "paramType": "Odds Ratio (OR)", "paramValue": "1.05", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.75", "ciUpperLimit": "1.49"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Percentage of Asthma Symptoms Free Days", "description": "All participants were provided with an electronic diary (e-Diary) to record clinical symptoms. They were instructed to routinely complete the e-Diary twice daily at the same time each morning and again approximately 12 hours later in the evening. The e-Diary was reviewed at each visit until study completion. Asthma symptoms free days are days with no daytime symptoms, no night-time awakenings and no symptoms on awakening. The daytime asthma symptom score was based on the daily e-diary recordings by participants with respect to shortness of breath, wheeze, cough, chest tightness, and impact on usual daily activities due to symptoms.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of days", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "401"}, {"groupId": "OG001", "value": "402"}, {"groupId": "OG002", "value": "408"}, {"groupId": "OG003", "value": "404"}, {"groupId": "OG004", "value": "405"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.3", "spread": "1.72"}, {"groupId": "OG001", "value": "28.4", "spread": "1.72"}, {"groupId": "OG002", "value": "22.5", "spread": "1.72"}, {"groupId": "OG003", "value": "19.3", "spread": "1.72"}, {"groupId": "OG004", "value": "24.9", "spread": "1.72"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.012", "statisticalMethod": "Linear Mixed Model (LMM)", "paramType": "LS Mean", "paramValue": "5.8", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.3", "ciUpperLimit": "10.2", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.29"}, {"groupIds": ["OG001", "OG003"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "9.1", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "4.6", "ciUpperLimit": "13.6", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.29"}, {"groupIds": ["OG000", "OG004"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.135", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "3.4", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-1.1", "ciUpperLimit": "7.9", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.29"}]}, {"type": "SECONDARY", "title": "Change Form Baseline in Percentage of Days With no Daytime Symptoms", "description": "All participants were provided with an electronic diary (e-Diary) to record clinical symptoms. They were instructed to routinely complete the e-Diary twice daily at the same time each morning and again approximately 12 hours later in the evening. The e-Diary was reviewed at each visit until study completion. For days with no daytime symptoms, all 5 evening questions must have a score = 0 with respect to shortness of breath, wheeze, cough, chest tightness and impact on usual daily activities due to symptoms, each with scores from 0 (no problems) to 4 (very severe problems).", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of days", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "416"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "425"}, {"groupId": "OG003", "value": "419"}, {"groupId": "OG004", "value": "423"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.0", "spread": "1.69"}, {"groupId": "OG001", "value": "28.0", "spread": "1.69"}, {"groupId": "OG002", "value": "23.0", "spread": "1.68"}, {"groupId": "OG003", "value": "20.0", "spread": "1.69"}, {"groupId": "OG004", "value": "24.8", "spread": "1.68"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.026", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "5.0", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.6", "ciUpperLimit": "9.4", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.25"}, {"groupIds": ["OG001", "OG003"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "8.1", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "3.7", "ciUpperLimit": "12.5", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.25"}, {"groupIds": ["OG000", "OG004"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.151", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "3.2", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-1.2", "ciUpperLimit": "7.7", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.25"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Percentage of Nights With no Night-time Awakenings", "description": "All participants were provided with an electronic diary (e-Diary) to record clinical symptoms. They were instructed to routinely complete the e-Diary twice daily at the same time each morning and again approximately 12 hours later in the evening. The e-Diary was reviewed at each visit until study completion. The question asked for nights with no night-time awakenings was \"How did you sleep last night?\" had to be answered with \"I did not wake up because of any breathing problems\" with scores from 0 (no problem)-4 (very severe problems).", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of nights", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "415"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "428"}, {"groupId": "OG003", "value": "422"}, {"groupId": "OG004", "value": "424"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "17.0", "spread": "1.28"}, {"groupId": "OG001", "value": "16.4", "spread": "1.27"}, {"groupId": "OG002", "value": "14.2", "spread": "1.27"}, {"groupId": "OG003", "value": "12.5", "spread": "1.27"}, {"groupId": "OG004", "value": "16.1", "spread": "1.27"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.104", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "2.8", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.6", "ciUpperLimit": "6.2", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1.72"}, {"groupIds": ["OG001", "OG003"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.024", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "3.9", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.5", "ciUpperLimit": "7.3", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1.72"}, {"groupIds": ["OG000", "OG004"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.588", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "0.9", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-2.5", "ciUpperLimit": "4.3", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1.73"}]}, {"type": "SECONDARY", "title": "Change Form Baseline in Percentage of Mornings With no Symptoms on Awakening", "description": "All participants were provided with an electronic diary (e-Diary) to record clinical symptoms. They were instructed to routinely complete the e-Diary twice daily at the same time each morning and again approximately 12 hours later in the evening. The e-Diary was reviewed at each visit until study completion. The question asked for mornings with no symptoms on awakening was \"Did you have asthma symptoms upon awakening in the morning?\" to be answered with \"None\" with scores from 0 (no problem)-4 (very severe problems).", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of mornings", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "415"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "428"}, {"groupId": "OG003", "value": "422"}, {"groupId": "OG004", "value": "424"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "25.5", "spread": "1.66"}, {"groupId": "OG001", "value": "22.9", "spread": "1.65"}, {"groupId": "OG002", "value": "19.1", "spread": "1.65"}, {"groupId": "OG003", "value": "14.1", "spread": "1.65"}, {"groupId": "OG004", "value": "20.7", "spread": "1.65"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.003", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "6.4", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "2.1", "ciUpperLimit": "10.7", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.19"}, {"groupIds": ["OG001", "OG003"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "8.9", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "4.6", "ciUpperLimit": "13.2", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.19"}, {"groupIds": ["OG000", "OG004"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.029", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "4.8", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.5", "ciUpperLimit": "9.1", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.2"}]}, {"type": "SECONDARY", "title": "Rescue Medication Usage", "description": "All participants were given salbutamol/albuterol to use as rescue medication throughout the study along with e-Diary to record rescue medication use. The number of puffs of rescue medication during the past 12 hours is recorded twice (morning/evening) by the participant prior to taking study medication. The mean daily number of puffs of rescue medication use will be calculated for each participant, done separately for morning (night-time), evening (daytime), and daily (night-time plus daytime) rescue medication use", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication. n represents number of participants included in the analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "number of puffs", "timeFrame": "Up to Weeks 26 and 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"title": "Week1-26 Mean night-time number of puffs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "418"}, {"groupId": "OG001", "value": "419"}, {"groupId": "OG002", "value": "430"}, {"groupId": "OG003", "value": "422"}, {"groupId": "OG004", "value": "426"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.38", "spread": "0.028"}, {"groupId": "OG001", "value": "-0.27", "spread": "0.028"}, {"groupId": "OG002", "value": "-0.26", "spread": "0.028"}, {"groupId": "OG003", "value": "-0.19", "spread": "0.028"}, {"groupId": "OG004", "value": "-0.34", "spread": "0.028"}]}]}, {"title": "Week1-26 Mean daytime number of puffs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "417"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "427"}, {"groupId": "OG003", "value": "419"}, {"groupId": "OG004", "value": "424"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.57", "spread": "0.035"}, {"groupId": "OG001", "value": "-0.46", "spread": "0.035"}, {"groupId": "OG002", "value": "-0.38", "spread": "0.035"}, {"groupId": "OG003", "value": "-0.34", "spread": "0.035"}, {"groupId": "OG004", "value": "-0.53", "spread": "0.035"}]}]}, {"title": "Week1-26 Mean daily number of puffs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "426"}, {"groupId": "OG001", "value": "428"}, {"groupId": "OG002", "value": "433"}, {"groupId": "OG003", "value": "428"}, {"groupId": "OG004", "value": "432"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.96", "spread": "0.059"}, {"groupId": "OG001", "value": "-0.73", "spread": "0.059"}, {"groupId": "OG002", "value": "-0.65", "spread": "0.059"}, {"groupId": "OG003", "value": "-0.53", "spread": "0.059"}, {"groupId": "OG004", "value": "-0.87", "spread": "0.059"}]}]}, {"title": "Week1-52 Mean night-time number of puffs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "415"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "428"}, {"groupId": "OG003", "value": "422"}, {"groupId": "OG004", "value": "424"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.40", "spread": "0.029"}, {"groupId": "OG001", "value": "-0.30", "spread": "0.029"}, {"groupId": "OG002", "value": "-0.29", "spread": "0.028"}, {"groupId": "OG003", "value": "-0.20", "spread": "0.029"}, {"groupId": "OG004", "value": "-0.35", "spread": "0.029"}]}]}, {"title": "Week 1-52 Mean daytime number of puffs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "416"}, {"groupId": "OG001", "value": "420"}, {"groupId": "OG002", "value": "425"}, {"groupId": "OG003", "value": "419"}, {"groupId": "OG004", "value": "423"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.60", "spread": "0.035"}, {"groupId": "OG001", "value": "-0.51", "spread": "0.035"}, {"groupId": "OG002", "value": "-0.43", "spread": "0.035"}, {"groupId": "OG003", "value": "-0.36", "spread": "0.035"}, {"groupId": "OG004", "value": "-0.55", "spread": "0.035"}]}]}, {"title": "Week 1-52 Mean daily number of puffs", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "426"}, {"groupId": "OG001", "value": "428"}, {"groupId": "OG002", "value": "433"}, {"groupId": "OG003", "value": "428"}, {"groupId": "OG004", "value": "432"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.00", "spread": "0.060"}, {"groupId": "OG001", "value": "-0.80", "spread": "0.060"}, {"groupId": "OG002", "value": "-0.72", "spread": "0.060"}, {"groupId": "OG003", "value": "-0.56", "spread": "0.060"}, {"groupId": "OG004", "value": "-0.91", "spread": "0.060"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Week1-26 Mean night-time number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.13", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.2", "ciUpperLimit": "-0.05", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.039"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 1-26 Mean night-time number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.035", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.08", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.16", "ciUpperLimit": "-0.01", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.039"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 1-26 Mean night-time number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.261", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.04", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.12", "ciUpperLimit": "0.03", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.039"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 1-26 Mean daytime number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.19", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.28", "ciUpperLimit": "-0.09", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.047"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 1-26 Mean daytime number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.011", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.12", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.21", "ciUpperLimit": "-0.03", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.047"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 1-26 Mean daytime number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.425", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.04", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.13", "ciUpperLimit": "0.06", "dispersionType": "STANDARD_DEVIATION", "dispersionValue": "0.047"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 1-26 Mean daily number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.31", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.46", "ciUpperLimit": "-0.15", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.081"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 1-26 Mean daily number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.017", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.19", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.35", "ciUpperLimit": "-0.03", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.081"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 1-26 Mean daily number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.29", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.09", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.24", "ciUpperLimit": "-0.07", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.081"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 1-52 Mean night-time number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.004", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.11", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.19", "ciUpperLimit": "-0.04", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.039"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 1-52 Mean night-time number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.019", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.09", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.17", "ciUpperLimit": "-0.02", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.039"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 1-52 Mean night-time number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.226", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.05", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.12", "ciUpperLimit": "0.03", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.039"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 1-52 Mean daytime number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.17", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.26", "ciUpperLimit": "-0.07", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.048"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 1-52 Mean daytime number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.002", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.15", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.24", "ciUpperLimit": "-0.05", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.048"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 1-52 Mean daytime number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.384", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.04", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.14", "ciUpperLimit": "0.05", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.048"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 1-52 Mean daily number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "< 0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.28", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.44", "ciUpperLimit": "-0.12", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.081"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Week 1-52 Mean daily number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.004", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.23", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.39", "ciUpperLimit": "-0.07", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.081"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Week 1-52 Mean daily number of puffs", "nonInferiorityType": "SUPERIORITY", "pValue": "0.245", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "-0.09", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.25", "ciUpperLimit": "0.06", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.081"}]}, {"type": "SECONDARY", "title": "Time to First Asthma Exacerbation by Exacerbation Category", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Full Range", "unitOfMeasure": "days", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"title": "Moderate or severe asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "366.0", "lowerLimit": "2", "upperLimit": "389"}, {"groupId": "OG001", "value": "366.0", "lowerLimit": "1", "upperLimit": "429"}, {"groupId": "OG002", "value": "366.0", "lowerLimit": "2", "upperLimit": "390"}, {"groupId": "OG003", "value": "364.0", "lowerLimit": "2", "upperLimit": "402"}, {"groupId": "OG004", "value": "366.0", "lowerLimit": "2", "upperLimit": "395"}]}]}, {"title": "Severe asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "367", "lowerLimit": "2", "upperLimit": "389"}, {"groupId": "OG001", "value": "366", "lowerLimit": "1", "upperLimit": "429"}, {"groupId": "OG002", "value": "366", "lowerLimit": "2", "upperLimit": "390"}, {"groupId": "OG003", "value": "366", "lowerLimit": "2", "upperLimit": "402"}, {"groupId": "OG004", "value": "366", "lowerLimit": "3", "upperLimit": "395"}]}]}, {"title": "All (mild, moderate or severe) asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "366.0", "lowerLimit": "2", "upperLimit": "389"}, {"groupId": "OG001", "value": "366.0", "lowerLimit": "1", "upperLimit": "429"}, {"groupId": "OG002", "value": "364.5", "lowerLimit": "2", "upperLimit": "390"}, {"groupId": "OG003", "value": "306.0", "lowerLimit": "2", "upperLimit": "402"}, {"groupId": "OG004", "value": "365.0", "lowerLimit": "2", "upperLimit": "394"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Moderate or severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.53", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.39", "ciUpperLimit": "0.72"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Moderate or severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.45", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.34", "ciUpperLimit": "0.6"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Moderate or severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.209", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.81", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.59", "ciUpperLimit": "1.12"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.003", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.54", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.36", "ciUpperLimit": "0.81"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.44", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.3", "ciUpperLimit": "0.63"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.115", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.71", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.47", "ciUpperLimit": "1.09"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "All asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.65", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.51", "ciUpperLimit": "0.82"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "All asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.48", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.38", "ciUpperLimit": "0.6"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "All asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.185", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.84", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.66", "ciUpperLimit": "1.08"}]}, {"type": "SECONDARY", "title": "Time to First Hospitalization for Asthma Exacerbation", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Full Range", "unitOfMeasure": "days", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "367.0", "lowerLimit": "2", "upperLimit": "389"}, {"groupId": "OG001", "value": "367.0", "lowerLimit": "1", "upperLimit": "429"}, {"groupId": "OG002", "value": "367.0", "lowerLimit": "2", "upperLimit": "390"}, {"groupId": "OG003", "value": "366.0", "lowerLimit": "2", "upperLimit": "402"}, {"groupId": "OG004", "value": "367.0", "lowerLimit": "3", "upperLimit": "395"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.337", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.51", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.13", "ciUpperLimit": "2.03"}, {"groupIds": ["OG001", "OG003"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.063", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.14", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.02", "ciUpperLimit": "1.11"}, {"groupIds": ["OG000", "OG004"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.599", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "1.62", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.27", "ciUpperLimit": "9.7"}]}, {"type": "SECONDARY", "title": "Annual Rate of Asthma Exacerbations by Exacerbation Category", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "exacerbations per year", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"title": "Moderate or severe asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.25", "lowerLimit": "0.20", "upperLimit": "0.32"}, {"groupId": "OG001", "value": "0.27", "lowerLimit": "0.21", "upperLimit": "0.34"}, {"groupId": "OG002", "value": "0.39", "lowerLimit": "0.32", "upperLimit": "0.48"}, {"groupId": "OG003", "value": "0.56", "lowerLimit": "0.46", "upperLimit": "0.68"}, {"groupId": "OG004", "value": "0.27", "lowerLimit": "0.22", "upperLimit": "0.34"}]}]}, {"title": "Severe asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.13", "lowerLimit": "0.09", "upperLimit": "0.17"}, {"groupId": "OG001", "value": "0.13", "lowerLimit": "0.10", "upperLimit": "0.18"}, {"groupId": "OG002", "value": "0.18", "lowerLimit": "0.13", "upperLimit": "0.23"}, {"groupId": "OG003", "value": "0.29", "lowerLimit": "0.23", "upperLimit": "0.38"}, {"groupId": "OG004", "value": "0.14", "lowerLimit": "0.10", "upperLimit": "0.19"}]}]}, {"title": "All (mild, moderate, severe) asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.49", "lowerLimit": "0.41", "upperLimit": "0.60"}, {"groupId": "OG001", "value": "0.48", "lowerLimit": "0.40", "upperLimit": "0.59"}, {"groupId": "OG002", "value": "0.74", "lowerLimit": "0.62", "upperLimit": "0.88"}, {"groupId": "OG003", "value": "1.05", "lowerLimit": "0.89", "upperLimit": "1.24"}, {"groupId": "OG004", "value": "0.52", "lowerLimit": "0.43", "upperLimit": "0.63"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Moderate or severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.008", "statisticalMethod": "Generalized linear model", "paramType": "Rate Ratio", "paramValue": "0.65", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.48", "ciUpperLimit": "0.89"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Moderate or severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Generalized linear model", "paramType": "Rate Ratio", "paramValue": "0.47", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.35", "ciUpperLimit": "0.64"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Moderate or severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.669", "statisticalMethod": "Generalized linear model", "paramType": "Rate Ratio", "paramValue": "0.93", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.67", "ciUpperLimit": "1.29"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.108", "statisticalMethod": "Generalized linear model", "paramType": "Rate Ratio", "paramValue": "0.71", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.47", "ciUpperLimit": "1.08"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Generalized linear model", "paramType": "Rate Ratio", "paramValue": "0.46", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.31", "ciUpperLimit": "0.67"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.597", "statisticalMethod": "Generalized linear model", "paramType": "Rate Ratio", "paramValue": "0.89", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.58", "ciUpperLimit": "1.37"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "All (mild, moderate, severe) asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.002", "statisticalMethod": "Generalized linear model", "paramType": "Rate Ratio", "paramValue": "0.67", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.52", "ciUpperLimit": "0.87"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "All (mild, moderate, severe) asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Generalized linear model", "paramType": "Rate Ratio", "paramValue": "0.46", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.36", "ciUpperLimit": "0.59"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "All (mild, moderate, severe) asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.681", "statisticalMethod": "Generalized linear model", "paramType": "Rate Ratio", "paramValue": "0.95", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.72", "ciUpperLimit": "1.23"}]}, {"type": "SECONDARY", "title": "Duration in Days of Asthma Exacerbations by Exacerbation Category", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "populationDescription": "FAS consisted of all participant in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "days", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"title": "Moderate or severe asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.6", "spread": "10.60"}, {"groupId": "OG001", "value": "3.0", "spread": "12.53"}, {"groupId": "OG002", "value": "3.7", "spread": "11.40"}, {"groupId": "OG003", "value": "5.8", "spread": "13.98"}, {"groupId": "OG004", "value": "3.1", "spread": "9.68"}]}]}, {"title": "Severe asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "6.02"}, {"groupId": "OG001", "value": "1.7", "spread": "8.48"}, {"groupId": "OG002", "value": "1.7", "spread": "6.07"}, {"groupId": "OG003", "value": "3.2", "spread": "9.16"}, {"groupId": "OG004", "value": "1.9", "spread": "7.76"}]}]}, {"title": "All(mild, moderate,severe) asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.4", "spread": "18.81"}, {"groupId": "OG001", "value": "5.0", "spread": "17.55"}, {"groupId": "OG002", "value": "6.9", "spread": "22.96"}, {"groupId": "OG003", "value": "10.1", "spread": "25.15"}, {"groupId": "OG004", "value": "5.1", "spread": "14.48"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Moderate or severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "van Elteren test"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Moderate or severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "van Elteren test"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Moderate or severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.059", "statisticalMethod": "van Elteren test"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Severe Asthma Exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.004", "statisticalMethod": "Van Elteren Test"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Severe Asthma Exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Van Elteren Test"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Severe asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.025", "statisticalMethod": "van Elteren test"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "All(mild, moderate, severe) Asthma Exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.002", "statisticalMethod": "Van Elteren Test"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "All (mild, moderate, severe) Asthma Exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Van Elteren Test"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "All (mild, moderate, severe) asthma exacerbation", "nonInferiorityType": "SUPERIORITY", "pValue": "0.074", "statisticalMethod": "van Elteren test"}]}, {"type": "SECONDARY", "title": "Percentage of Participants With at Least One Asthma Exacerbation by Exacerbation Category", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "populationDescription": "FAS consisted of all patients in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"title": "Moderate or severe asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "14.9"}, {"groupId": "OG001", "value": "16.9"}, {"groupId": "OG002", "value": "26.1"}, {"groupId": "OG003", "value": "32.5"}, {"groupId": "OG004", "value": "19.1"}]}]}, {"title": "Severe asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.1"}, {"groupId": "OG001", "value": "9.8"}, {"groupId": "OG002", "value": "14.5"}, {"groupId": "OG003", "value": "20.1"}, {"groupId": "OG004", "value": "11.9"}]}]}, {"title": "Moderate asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.7"}, {"groupId": "OG001", "value": "8.2"}, {"groupId": "OG002", "value": "14.3"}, {"groupId": "OG003", "value": "16.5"}, {"groupId": "OG004", "value": "9.2"}]}]}, {"title": "Mild asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "13.3"}, {"groupId": "OG001", "value": "12.1"}, {"groupId": "OG002", "value": "17.5"}, {"groupId": "OG003", "value": "19.6"}, {"groupId": "OG004", "value": "15.1"}]}]}, {"title": "All (mild, moderate, severe) asthma exacerbation", "categories": [{"measurements": [{"groupId": "OG000", "value": "25.5"}, {"groupId": "OG001", "value": "25.6"}, {"groupId": "OG002", "value": "36.1"}, {"groupId": "OG003", "value": "44.5"}, {"groupId": "OG004", "value": "30.6"}]}]}]}, {"type": "SECONDARY", "title": "Time in Days to Permanent Discontinuation of Study Medication Due to Asthma Exacerbations", "description": "The exacerbation categories were: All (mild, moderate and severe) and combination of moderate or severe and severe.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Full Range", "unitOfMeasure": "days", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol /Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "367.0", "lowerLimit": "2", "upperLimit": "389"}, {"groupId": "OG001", "value": "367.0", "lowerLimit": "1", "upperLimit": "429"}, {"groupId": "OG002", "value": "367.0", "lowerLimit": "2", "upperLimit": "390"}, {"groupId": "OG003", "value": "366.0", "lowerLimit": "2", "upperLimit": "402"}, {"groupId": "OG004", "value": "367.0", "lowerLimit": "3", "upperLimit": "395"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.222", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.26", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.03", "ciUpperLimit": "2.29"}, {"groupIds": ["OG001", "OG003"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.992", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0", "ciUpperLimitComment": "The upper limit of CI could not be calculated due to low number of participants with asthma exacerbation."}, {"groupIds": ["OG000", "OG004"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.618", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.54", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.05", "ciUpperLimit": "6.01"}]}, {"type": "SECONDARY", "title": "Percentage of Participants Who Permanently Discontinued Study Medication Due to Asthma Exacerbations", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.2"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0.9"}, {"groupId": "OG003", "value": "1.6"}, {"groupId": "OG004", "value": "0.5"}]}]}]}, {"type": "SECONDARY", "title": "Total Amounts of Systemic Corticosteroids (in Doses) Used to Treat Asthma Exacerbations", "description": "The treatment of asthma exacerbations including the initiation of systemic corticosteroids were done according to investigator's or treating physician's medical judgement and in line with national and international recommendations. If systemic corticosteroids were required, a participant could return to the study after successfully completing a taper of approximately 7-10 days.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "milligrams", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "26.0", "spread": "136.92"}, {"groupId": "OG001", "value": "29.9", "spread": "124.98"}, {"groupId": "OG002", "value": "28.0", "spread": "95.18"}, {"groupId": "OG003", "value": "47.8", "spread": "139.98"}, {"groupId": "OG004", "value": "26.9", "spread": "114.36"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in Percentage of Rescue Medication Free Days", "description": "All participants were given salbutamol/albuterol to use as rescue medication throughout the study along with e-Diary to record rescue medication use. Rescue medication free days is defined as any day where the participant did not use any puffs of rescue medication during daytime and night-time.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication. n represents number of participants with data at respective visit.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of days", "timeFrame": "Up to Weeks 26 and 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d via Concept1 inhaler in the evening"}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d via Concept1 inhaler in the evening"}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d via Twisthaler\u00ae in the evening"}, {"id": "OG004", "title": "Salmeterol /Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"title": "Weeks 1-26", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "412"}, {"groupId": "OG001", "value": "416"}, {"groupId": "OG002", "value": "424"}, {"groupId": "OG003", "value": "414"}, {"groupId": "OG004", "value": "421"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "31.5", "spread": "1.53"}, {"groupId": "OG001", "value": "27.4", "spread": "1.53"}, {"groupId": "OG002", "value": "21.4", "spread": "1.52"}, {"groupId": "OG003", "value": "19.1", "spread": "1.53"}, {"groupId": "OG004", "value": "27.4", "spread": "1.52"}]}]}, {"title": "Weeks 1-52", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "408"}, {"groupId": "OG001", "value": "416"}, {"groupId": "OG002", "value": "420"}, {"groupId": "OG003", "value": "414"}, {"groupId": "OG004", "value": "416"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "33.1", "spread": "1.55"}, {"groupId": "OG001", "value": "29.4", "spread": "1.54"}, {"groupId": "OG002", "value": "23.5", "spread": "1.54"}, {"groupId": "OG003", "value": "20.8", "spread": "1.54"}, {"groupId": "OG004", "value": "28.8", "spread": "1.54"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Weeks 1-26", "nonInferiorityType": "SUPERIORITY", "pValue": "< 0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "10.1", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "6.2", "ciUpperLimit": "14.1", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.02"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Weeks 1-26", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "8.3", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "4.3", "ciUpperLimit": "12.3", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.02"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Weeks 1-26", "nonInferiorityType": "SUPERIORITY", "pValue": "0.045", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "4.1", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.1", "ciUpperLimit": "8", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.02"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Weeks 1-52", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "9.6", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "5.7", "ciUpperLimit": "13.6", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.03"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Weeks 1-52", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "8.6", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "4.7", "ciUpperLimit": "12.6", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.03"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Weeks 1-52", "nonInferiorityType": "SUPERIORITY", "pValue": "0.034", "statisticalMethod": "LMM", "paramType": "LS Mean", "paramValue": "4.3", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.3", "ciUpperLimit": "8.3", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.04"}]}, {"type": "SECONDARY", "title": "Asthma Quality of Life Questionnaire (AQLQ)", "description": "AQLQ is a 32-item disease specific questionnaire designed to measure functional impairments that are most important to patients with asthma, with a recall time of two weeks and each question to be answered on a 7-point scale (1-totally limited/problems all the time, 7-not at all limited/no problems). It consists of 4 domains:\n\n* Symptoms = Mean of Items 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 29, 30 (12 items)\n* Activity limitation = Mean of Items 1, 2, 3, 4, 5, 11, 19, 25, 28, 31, 32 (11 items)\n* Emotional function = Mean of Items 7, 13, 15, 21, 27 (5 items)\n* Environmental stimuli = Mean of Items 9, 17, 23, 26 (4 items)\n* Overall Score = Mean of Items 1 to 32 (32 items)", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "score on a scale", "timeFrame": "Up to Week 52 (Day 364)", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "428"}, {"groupId": "OG001", "value": "426"}, {"groupId": "OG002", "value": "431"}, {"groupId": "OG003", "value": "428"}, {"groupId": "OG004", "value": "438"}]}], "classes": [{"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "427"}, {"groupId": "OG001", "value": "423"}, {"groupId": "OG002", "value": "430"}, {"groupId": "OG003", "value": "425"}, {"groupId": "OG004", "value": "436"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.560", "spread": "0.0327"}, {"groupId": "OG001", "value": "5.498", "spread": "0.0328"}, {"groupId": "OG002", "value": "5.413", "spread": "0.0326"}, {"groupId": "OG003", "value": "5.374", "spread": "0.0327"}, {"groupId": "OG004", "value": "5.515", "spread": "0.0324"}]}]}, {"title": "Day 86", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "419"}, {"groupId": "OG001", "value": "416"}, {"groupId": "OG002", "value": "422"}, {"groupId": "OG003", "value": "406"}, {"groupId": "OG004", "value": "428"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.618", "spread": "0.0356"}, {"groupId": "OG001", "value": "5.629", "spread": "0.0357"}, {"groupId": "OG002", "value": "5.564", "spread": "0.0355"}, {"groupId": "OG003", "value": "5.510", "spread": "0.0359"}, {"groupId": "OG004", "value": "5.592", "spread": "0.0352"}]}]}, {"title": "Day 183", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "406"}, {"groupId": "OG001", "value": "407"}, {"groupId": "OG002", "value": "405"}, {"groupId": "OG003", "value": "393"}, {"groupId": "OG004", "value": "410"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.724", "spread": "0.0372"}, {"groupId": "OG001", "value": "5.738", "spread": "0.0372"}, {"groupId": "OG002", "value": "5.598", "spread": "0.0372"}, {"groupId": "OG003", "value": "5.581", "spread": "0.0376"}, {"groupId": "OG004", "value": "5.639", "spread": "0.0369"}]}]}, {"title": "Day 254", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "392"}, {"groupId": "OG001", "value": "395"}, {"groupId": "OG002", "value": "388"}, {"groupId": "OG003", "value": "385"}, {"groupId": "OG004", "value": "405"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.761", "spread": "0.0383"}, {"groupId": "OG001", "value": "5.781", "spread": "0.0382"}, {"groupId": "OG002", "value": "5.689", "spread": "0.0383"}, {"groupId": "OG003", "value": "5.614", "spread": "0.0386"}, {"groupId": "OG004", "value": "5.700", "spread": "0.0378"}]}]}, {"title": "Day 364", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "384"}, {"groupId": "OG001", "value": "397"}, {"groupId": "OG002", "value": "389"}, {"groupId": "OG003", "value": "378"}, {"groupId": "OG004", "value": "405"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.783", "spread": "0.0391"}, {"groupId": "OG001", "value": "5.832", "spread": "0.0388"}, {"groupId": "OG002", "value": "5.705", "spread": "0.0389"}, {"groupId": "OG003", "value": "5.641", "spread": "0.0394"}, {"groupId": "OG004", "value": "5.742", "spread": "0.0384"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Day 30", "nonInferiorityType": "SUPERIORITY", "pValue": "0.002", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.147", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.056", "ciUpperLimit": "0.237", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0462"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 30", "nonInferiorityType": "SUPERIORITY", "pValue": "0.008", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.123", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.032", "ciUpperLimit": "0.214", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0464"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 30", "nonInferiorityType": "SUPERIORITY", "pValue": "0.33", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.045", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.045", "ciUpperLimit": "0.135", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.046"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 86", "nonInferiorityType": "SUPERIORITY", "pValue": "0.28", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.054", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.044", "ciUpperLimit": "0.153", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0503"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 86", "nonInferiorityType": "SUPERIORITY", "pValue": "0.02", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.118", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.019", "ciUpperLimit": "0.217", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0507"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 86", "nonInferiorityType": "SUPERIORITY", "pValue": "0.598", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.026", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.072", "ciUpperLimit": "0.125", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0501"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 183", "nonInferiorityType": "SUPERIORITY", "pValue": "0.016", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.127", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.023", "ciUpperLimit": "0.23", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0526"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 183", "nonInferiorityType": "SUPERIORITY", "pValue": "0.003", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.156", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.053", "ciUpperLimit": "0.26", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0529"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 183", "nonInferiorityType": "SUPERIORITY", "pValue": "0.103", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.085", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.017", "ciUpperLimit": "0.188", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0525"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 254", "nonInferiorityType": "SUPERIORITY", "pValue": "0.188", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.071", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.035", "ciUpperLimit": "0.178", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0542"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 254", "nonInferiorityType": "SUPERIORITY", "pValue": "0.002", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.168", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.061", "ciUpperLimit": "0.274", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0543"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 254", "nonInferiorityType": "SUPERIORITY", "pValue": "0.258", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.061", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.045", "ciUpperLimit": "0.166", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0538"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Day 364", "nonInferiorityType": "SUPERIORITY", "pValue": "0.154", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.079", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.030", "ciUpperLimit": "0.187", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0552"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Day 364", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.191", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.082", "ciUpperLimit": "0.299", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0553"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Day 364", "nonInferiorityType": "SUPERIORITY", "pValue": "0.455", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.041", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.067", "ciUpperLimit": "0.148", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0548"}]}, {"type": "SECONDARY", "title": "Trough FEV1 Measured After 26 Weeks of Treatment", "description": "Trough FEV1 was assessed by performing spirometric assessment. It is defined as average of the two FEV1 measurements taken 23 hr 15 min and 23 hr 45 min post-evening dose. FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing.", "populationDescription": "FAS consisted of all participants in the RAN set who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "L", "timeFrame": "Week 26", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "395"}, {"groupId": "OG001", "value": "389"}, {"groupId": "OG002", "value": "372"}, {"groupId": "OG003", "value": "376"}, {"groupId": "OG004", "value": "391"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.383", "spread": "0.0159"}, {"groupId": "OG001", "value": "2.387", "spread": "0.0160"}, {"groupId": "OG002", "value": "2.250", "spread": "0.0162"}, {"groupId": "OG003", "value": "2.176", "spread": "0.0162"}, {"groupId": "OG004", "value": "2.346", "spread": "0.0160"}]}]}], "analyses": [{"groupIds": ["OG000", "OG004"], "nonInferiorityType": "NON_INFERIORITY", "nonInferiorityComment": "QMF 150/320 was considered non-inferior to S/F 50/500 if the lower bound of the 95% CI was above the non-inferiority margin of -90 mL and was considered superior if the lower bound of the 95% CI was \\> 0. The p-value is for null-hypothesis testing.", "pValue": "0.101", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.036", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.007", "ciUpperLimit": "0.080", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0222"}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Composite Endpoint of Serious Asthma Outcomes", "description": "A composite endpoint of serious asthma outcomes is defined as asthma-related hospitalization, asthma-related intubation, or asthma-related death and was reviewed by the Adjudication Committee.", "populationDescription": "Safety Set consisted of all participants who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "Up to Week 52", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.7"}, {"groupId": "OG001", "value": "0.5"}, {"groupId": "OG002", "value": "1.6"}, {"groupId": "OG003", "value": "1.8"}, {"groupId": "OG004", "value": "0.5"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)", "description": "An AE is any untoward medical occurrence (i.e., any unfavorable and unintended sign including abnormal laboratory findings, symptom or disease) in a participant or clinical investigation participant after providing written informed consent for participation in the study. An SAE is defined as any adverse event (appearance of (or worsening of any pre-existing) undesirable sign(s), symptom(s) or medical conditions(s) which meets any one of the following criteria: is fatal or life-threatening, results in persistent or significant disability/incapacity, constitutes a congenital anomaly/birth defect, requires inpatient hospitalization or prolongation of existing hospitalization or is medically significant, i.e. defined as an event that jeopardizes the participants or may require medical or surgical intervention.", "populationDescription": "Safety Set consisted of all participants who received at least one dose of study medication.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "Approximately up to 56 weeks", "groups": [{"id": "OG000", "title": "QMF149 150/320 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG001", "title": "QMF149 150/160 \u03bcg", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening."}, {"id": "OG002", "title": "MF 800 \u03bcg", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae."}, {"id": "OG003", "title": "MF 400 \u03bcg", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening."}, {"id": "OG004", "title": "Salmeterol/Fluticasone 50/500 \u03bcg", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "443"}, {"groupId": "OG001", "value": "437"}, {"groupId": "OG002", "value": "440"}, {"groupId": "OG003", "value": "443"}, {"groupId": "OG004", "value": "444"}]}], "classes": [{"title": "Adverse Events(AEs)", "categories": [{"measurements": [{"groupId": "OG000", "value": "64.6"}, {"groupId": "OG001", "value": "66.8"}, {"groupId": "OG002", "value": "70.0"}, {"groupId": "OG003", "value": "72.2"}, {"groupId": "OG004", "value": "65.3"}]}]}, {"title": "Serious Adverse Events(SAEs)", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.7"}, {"groupId": "OG001", "value": "4.6"}, {"groupId": "OG002", "value": "4.8"}, {"groupId": "OG003", "value": "7.0"}, {"groupId": "OG004", "value": "4.7"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "2", "timeFrame": "Serious adverse events: From first dose up to 30 days post last dose (approximately 56 weeks) Other adverse events: From first dose up to 7 days post last dose (approximately 53 weeks)", "description": "The Safety Set consisted of all participants who received at least one dose of study medication.", "eventGroups": [{"id": "EG000", "title": "QMF 150/320", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/320 \u03bcg was delivered o.d. via Concept1 inhaler in the evening.", "deathsNumAffected": 0, "deathsNumAtRisk": 443, "seriousNumAffected": 21, "seriousNumAtRisk": 443, "otherNumAffected": 228, "otherNumAtRisk": 443}, {"id": "EG001", "title": "QMF 150/160", "description": "QMF149 (Indacaterol acetate/Mometasone furoate) 150/160 \u03bcg was delivered o.d. via Concept1 inhaler in the evening.", "deathsNumAffected": 0, "deathsNumAtRisk": 437, "seriousNumAffected": 20, "seriousNumAtRisk": 437, "otherNumAffected": 233, "otherNumAtRisk": 437}, {"id": "EG002", "title": "MF 800", "description": "MF 800 \u03bcg of total daily dose (400 \u03bcg twice daily, in the morning and in the evening) was delivered via Twisthaler\u00ae.", "deathsNumAffected": 0, "deathsNumAtRisk": 440, "seriousNumAffected": 21, "seriousNumAtRisk": 440, "otherNumAffected": 263, "otherNumAtRisk": 440}, {"id": "EG003", "title": "MF 400", "description": "MF 400 \u03bcg was delivered o.d. via Twisthaler\u00ae in the evening.", "deathsNumAffected": 1, "deathsNumAtRisk": 443, "seriousNumAffected": 31, "seriousNumAtRisk": 443, "otherNumAffected": 290, "otherNumAtRisk": 443}, {"id": "EG004", "title": "S/F 50/500", "description": "Salmeterol xinafoate/fluticasone propionate 50/500 \u03bcg was delivered twice daily (in the morning and in the evening) via Accuhaler\u00ae.", "deathsNumAffected": 0, "deathsNumAtRisk": 444, "seriousNumAffected": 21, "seriousNumAtRisk": 444, "otherNumAffected": 239, "otherNumAtRisk": 444}], "seriousEvents": [{"term": "Acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Coronary artery disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Vertigo", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Goitre", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Corneal deposits", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Optic ischaemic neuropathy", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Retinal detachment", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Abdominal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Diverticulum intestinal", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Diverticulum intestinal haemorrhagic", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Gastric polyps", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Gastric ulcer haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Inguinal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Irritable bowel syndrome", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Large intestine polyp", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Pancreatitis acute", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Peptic ulcer", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Cholecystitis acute", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Cholelithiasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Appendicitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Complicated appendicitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Dengue fever", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Diverticulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Gastroenteritis salmonella", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Otitis media", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Peritonitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 3, "numAtRisk": 444}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Pneumonia viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Pulmonary tuberculosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Respiratory tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Sialoadenitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Upper respiratory tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Accidental device ingestion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Ankle fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Clavicle fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Concussion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Eye injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Forearm fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Hand fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Head injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Humerus fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Ligament sprain", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Meniscus injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Postoperative wound complication", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Radius fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Rib fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Alanine aminotransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Aspartate aminotransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Blood bilirubin increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Diabetes mellitus inadequate control", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Electrolyte imbalance", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Type 2 diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Arthropathy", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Bursitis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Foot deformity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Intervertebral disc protrusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Joint effusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Osteochondrosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Osteoporosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Rotator cuff syndrome", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Papillary thyroid cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Renal neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Uterine cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Uterine leiomyoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Cerebellar haematoma", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Cerebral infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Hydrocephalus", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Intracranial aneurysm", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Migraine with aura", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Sciatica", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Subarachnoid haemorrhage", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Vertebral artery aneurysm", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Depression", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Calculus urethral", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Hydronephrosis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Hydroureter", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Ureteric stenosis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Ureterolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Urethral stenosis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Benign prostatic hyperplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Cervical dysplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Cervix enlargement", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Endometrial hyperplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Endometriosis", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Metrorrhagia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Vaginal prolapse", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Asphyxia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 8, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 444}]}, {"term": "Atelectasis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Chronic rhinosinusitis with nasal polyps", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Haemothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Hydrothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Nasal polyps", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 444}]}, {"term": "Nasal septum deviation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Pleurisy", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Pulmonary mass", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Angioedema", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Dermatitis atopic", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Aortic dissection", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}, {"term": "Hypertensive crisis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 444}]}], "otherEvents": [{"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 9, "numAtRisk": 444}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 20, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 22, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 22, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 21, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 17, "numAtRisk": 444}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 6, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 444}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 13, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 19, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 10, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 15, "numAtRisk": 444}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 50, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 58, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 78, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 82, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 47, "numAtRisk": 444}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 11, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 12, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 12, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 14, "numAtRisk": 444}]}, {"term": "Respiratory tract infection viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 16, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 14, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 12, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 13, "numAtRisk": 444}]}, {"term": "Rhinitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 10, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 5, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 444}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 22, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 27, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 40, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 37, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 38, "numAtRisk": 444}]}, {"term": "Upper respiratory tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 14, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 444}]}, {"term": "Viral infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 11, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 7, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 6, "numAtRisk": 444}]}, {"term": "Viral upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 11, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 21, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 20, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 21, "numAtRisk": 444}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 9, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 17, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 5, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 444}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 26, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 21, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 24, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 23, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 22, "numAtRisk": 444}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 112, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 113, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 157, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 194, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 137, "numAtRisk": 444}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 12, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 15, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 444}]}, {"term": "Oropharyngeal pain", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 8, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 9, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 444}]}, {"term": "Rhinitis allergic", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 11, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 11, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 7, "numAtRisk": 444}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 443}, {"groupId": "EG001", "numAffected": 14, "numAtRisk": 437}, {"groupId": "EG002", "numAffected": 13, "numAtRisk": 440}, {"groupId": "EG003", "numAffected": 11, "numAtRisk": 443}, {"groupId": "EG004", "numAffected": 6, "numAtRisk": 444}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety."}, "pointOfContact": {"title": "Study Director", "organization": "Novartis Pharmaceuticals", "email": "novartis.email@novartis.com", "phone": "862-778-8300"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2018-01-17", "uploadDate": "2019-12-11T18:36", "filename": "Prot_000.pdf", "size": 1318264}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2018-09-27", "uploadDate": "2019-12-11T18:37", "filename": "SAP_001.pdf", "size": 635039}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Czech Republic"]}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068298", "term": "Fluticasone"}, {"id": "C000716389", "term": "Xhance"}, {"id": "D000068656", "term": "Mometasone Furoate"}, {"id": "D000068299", "term": "Salmeterol Xinafoate"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M290", "name": "Mometasone Furoate", "asFound": "Tea", "relevance": "HIGH"}, {"id": "M250", "name": "Fluticasone", "asFound": "Membrane", "relevance": "HIGH"}, {"id": "M353494", "name": "Xhance", "asFound": "Membrane", "relevance": "HIGH"}, {"id": "M251", "name": "Salmeterol Xinafoate", "asFound": "Healthy diet", "relevance": "HIGH"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}]}}, "hasResults": true}